1
|
Echevarria MAN, Batistuzzo MC, Silva RMF, Brunoni AR, Sato JR, Miguel EC, Hoexter MQ, Shavitt RG. Increases in functional connectivity between the default mode network and sensorimotor network correlate with symptomatic improvement after transcranial direct current stimulation for obsessive-compulsive disorder. J Affect Disord 2024; 355:175-183. [PMID: 38548207 DOI: 10.1016/j.jad.2024.03.141] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/18/2023] [Revised: 03/10/2024] [Accepted: 03/24/2024] [Indexed: 04/04/2024]
Abstract
BACKGROUND Non-invasive neuromodulation is a promising intervention for obsessive-compulsive disorder (OCD), although its neurobiological mechanisms of action are still poorly understood. Recent evidence suggests that abnormalities in the connectivity of the default mode network (DMN) and the supplementary motor area (SMA) with other brain regions and networks are involved in OCD pathophysiology. We examined if transcranial direct current stimulation (tDCS) alters these connectivity patterns and if they correlate with symptom improvement in treatment-resistant OCD. METHODS In 23 patients from a larger clinical trial (comparing active tDCS to sham) who underwent pre- and post-treatment MRI scans, we assessed resting-state functional MRI (rs-fMRI) data. The treatment involved 30-minute daily tDCS sessions for four weeks (weekdays only), with the cathode over the SMA and the anode over the left deltoid. We conducted whole-brain connectivity analysis comparing active tDCS-treated to sham-treated patients. RESULTS We found that active tDCS, but not sham, led to connectivity increasing between the DMN and the bilateral pre/postcentral gyri (p = 0.004, FDR corrected) and temporal-auditory areas plus the SMA (p = 0.028, FDR corrected). Also, symptom improvement was directly associated with connectivity increasing between the left lateral sensorimotor network and the left precuneus (r = 0.589, p = 0.034). LIMITATIONS Limited sample size (23 participants with resting-state neuroimaging), inability to analyze specific OCD symptom dimensions (e.g., harm, sexual/religious, symmetry/checking, cleaning/contamination). CONCLUSIONS These data offer novel information concerning functional connectivity changes associated with non-invasive neuromodulation interventions in OCD and can guide new brain stimulation interventions in the framework of personalized interventions.
Collapse
Affiliation(s)
- M A N Echevarria
- LIM-23, Department of Psychiatry, Faculdade de Medicina, Universidade de São Paulo, SP, Brazil.
| | - M C Batistuzzo
- LIM-23, Department of Psychiatry, Faculdade de Medicina, Universidade de São Paulo, SP, Brazil; Department of Methods and Techniques in Psychology, Pontifical Catholic University, São Paulo, SP, Brazil
| | - R M F Silva
- LIM-23, Department of Psychiatry, Faculdade de Medicina, Universidade de São Paulo, SP, Brazil
| | - A R Brunoni
- LIM-23, Department of Psychiatry, Faculdade de Medicina, Universidade de São Paulo, SP, Brazil
| | - J R Sato
- Center of Mathematics, Computing and Cognition, Universidade Federal do ABC, SP, Brazil
| | - E C Miguel
- LIM-23, Department of Psychiatry, Faculdade de Medicina, Universidade de São Paulo, SP, Brazil
| | - M Q Hoexter
- LIM-23, Department of Psychiatry, Faculdade de Medicina, Universidade de São Paulo, SP, Brazil
| | - R G Shavitt
- LIM-23, Department of Psychiatry, Faculdade de Medicina, Universidade de São Paulo, SP, Brazil
| |
Collapse
|
2
|
Ramirez-Mahaluf JP, Medel V, Tepper Á, Alliende LM, Sato JR, Ossandon T, Crossley NA. Transitions between human functional brain networks reveal complex, cost-efficient and behaviorally-relevant temporal paths. Neuroimage 2020; 219:117027. [DOI: 10.1016/j.neuroimage.2020.117027] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2020] [Revised: 06/02/2020] [Accepted: 06/04/2020] [Indexed: 01/20/2023] Open
|
3
|
Kong XZ, Boedhoe PS, Abe Y, Alonso P, Ameis SH, Arnold PD, Assogna F, Baker JT, Batistuzzo MC, Benedetti F, Beucke JC, Bollettini I, Bose A, Brem S, Brennan BP, Buitelaar J, Calvo R, Cheng Y, Cho KIK, Dallaspezia S, Denys D, Ely BA, Feusner J, Fitzgerald KD, Fouche JP, Fridgeirsson EA, Glahn DC, Gruner P, Gürsel DA, Hauser TU, Hirano Y, Hoexter MQ, Hu H, Huyser C, James A, Jaspers-Fayer F, Kathmann N, Kaufmann C, Koch K, Kuno M, Kvale G, Kwon JS, Lazaro L, Liu Y, Lochner C, Marques P, Marsh R, Martínez-Zalacaín I, Mataix-Cols D, Medland SE, Menchón JM, Minuzzi L, Moreira PS, Morer A, Morgado P, Nakagawa A, Nakamae T, Nakao T, Narayanaswamy JC, Nurmi EL, O’Neil J, Pariente JC, Perriello C, Piacentini J, Piras F, Piras F, Pittenger C, Reddy YJ, Rus-Oswald OG, Sakai Y, Sato JR, Schmaal L, Simpson HB, Soreni N, Soriano-Mas C, Spalletta G, Stern ER, Stevens MC, Stewart SE, Szeszko PR, Tolin DF, Tsuchiyagaito A, van Rooij D, van Wingen GA, Venkatasubramanian G, Wang Z, Yun JY, Thompson PM, Stein DJ, van den Heuvel OA, Francks C. Mapping Cortical and Subcortical Asymmetry in Obsessive-Compulsive Disorder: Findings From the ENIGMA Consortium. Biol Psychiatry 2020; 87:1022-1034. [PMID: 31178097 PMCID: PMC7094802 DOI: 10.1016/j.biopsych.2019.04.022] [Citation(s) in RCA: 59] [Impact Index Per Article: 14.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/20/2018] [Revised: 03/21/2019] [Accepted: 04/10/2019] [Indexed: 12/13/2022]
Abstract
BACKGROUND Lateralized dysfunction has been suggested in obsessive-compulsive disorder (OCD). However, it is currently unclear whether OCD is characterized by abnormal patterns of brain structural asymmetry. Here we carried out what is by far the largest study of brain structural asymmetry in OCD. METHODS We studied a collection of 16 pediatric datasets (501 patients with OCD and 439 healthy control subjects), as well as 30 adult datasets (1777 patients and 1654 control subjects) from the OCD Working Group within the ENIGMA (Enhancing Neuro Imaging Genetics through Meta Analysis) Consortium. Asymmetries of the volumes of subcortical structures, and of measures of regional cortical thickness and surface areas, were assessed based on T1-weighted magnetic resonance imaging scans, using harmonized image analysis and quality control protocols. We investigated possible alterations of brain asymmetry in patients with OCD. We also explored potential associations of asymmetry with specific aspects of the disorder and medication status. RESULTS In the pediatric datasets, the largest case-control differences were observed for volume asymmetry of the thalamus (more leftward; Cohen's d = 0.19) and the pallidum (less leftward; d = -0.21). Additional analyses suggested putative links between these asymmetry patterns and medication status, OCD severity, or anxiety and depression comorbidities. No significant case-control differences were found in the adult datasets. CONCLUSIONS The results suggest subtle changes of the average asymmetry of subcortical structures in pediatric OCD, which are not detectable in adults with the disorder. These findings may reflect altered neurodevelopmental processes in OCD.
Collapse
Affiliation(s)
- Xiang-Zhen Kong
- Language and Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen, The Netherlands.
| | - Premika S.W. Boedhoe
- Amsterdam UMC, Vrije Universteit Amsterdam, Department of Psychiatry, Amsterdam Neuroscience, Amsterdam, The Netherlands.,Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Anatomy & Neurosciences, Amsterdam Neuroscience, Amsterdam, The Netherlands
| | - Yoshinari Abe
- Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - Pino Alonso
- Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain.,Centro de Investigación Biomèdica en Red de Salud Mental-CIBERSAM, Barcelona, Spain.,Department of Clinical Sciences, University of Barcelona, Spain
| | - Stephanie H. Ameis
- The Margaret and Wallace McCain Centre for Child, Youth & Family Mental Health, Campbell Family Mental Health Research Institute, The Centre for Addiction and Mental Health, Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Canada.,Centre for Brain and Mental Health, The Hospital for Sick Children, Toronto, Canada
| | - Paul D. Arnold
- Mathison Centre for Mental Health Research & Education, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.,Department of Psychiatry, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
| | - Francesca Assogna
- Laboratory of Neuropsychiatry, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy
| | | | - Marcelo C. Batistuzzo
- Departamento e Instituto de Psiquiatria do Hospital das Clinicas, IPQ HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, SP, Brasil
| | - Francesco Benedetti
- Psychiatry and Clinical Psychobiology, Division of Neuroscience, Scientific Institute Ospedale San Raffaele, Milano, Italy
| | - Jan C. Beucke
- Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany
| | - Irene Bollettini
- Psychiatry and Clinical Psychobiology, Division of Neuroscience, Scientific Institute Ospedale San Raffaele, Milano, Italy
| | - Anushree Bose
- Obsessive-Compulsive Disorder (OCD) Clinic Department of Psychiatry National Institute of Mental Health & Neurosciences, Bangalore, India
| | - Silvia Brem
- Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric Hospital, University of Zurich, Zurich, Switzerland.,Neuroscience Center Zurich, University of Zurich and ETH Zurich, Zurich, Switzerland
| | | | - Jan Buitelaar
- Department of Cognitive Neurosicence, Donders Institute for Brain, Cognition and Behavior, Radboudumc, Nijmegen, The Netherlands
| | - Rosa Calvo
- Department of Child and Adolescent Psychiatry and Psychology, Institute of Neurosciences, Hospital Clínic Universitari, Barcelona, Spain.,Department of Medicine, University of Barcelona, Barcelona, Spain.,Centro de Investigación Biomédica en red de Salud Mental (CIBERSAM), Spain
| | - Yuqi Cheng
- Department of Psychiatry, First Affiliated Hospital of Kunming Medical University, Kunming, China
| | - Kang Ik K. Cho
- Institute of Human Behavioral Medicine, SNU-MRC, Seoul, Republic of Korea
| | - Sara Dallaspezia
- Psychiatry and Clinical Psychobiology, Division of Neuroscience, Scientific Institute Ospedale San Raffaele, Milano, Italy
| | - Damiaan Denys
- Amsterdam UMC, University of Amsterdam, Department of Psychiatry, Amsterdam Neuroscience, Amsterdam, Netherlands.,Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences, Amsterdam, The Netherlands
| | - Benjamin A. Ely
- Department of Neuroscience, Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, U.S.A
| | - Jamie Feusner
- Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA, U.S.A
| | - Kate D. Fitzgerald
- Department of Psychiatry, University of Michigan, Ann Arbor, Michigan, U.S.A
| | - Jean-Paul Fouche
- Department of Psychiatry, University of Cape Town, Cape Town, South Africa.,Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa
| | - Egill A. Fridgeirsson
- Amsterdam UMC, University of Amsterdam, Department of Psychiatry, Amsterdam Neuroscience, Amsterdam, Netherlands
| | - David C. Glahn
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.,Olin Neuropsychiatric Research Center, Hartford, CT, USA
| | - Patricia Gruner
- Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, U.S.A
| | - Deniz A. Gürsel
- Department of Neuroradiology, Klinikum rechts der Isar, Technische Universität München, Germany.,TUM-Neuroimaging Center (TUM-NIC) of Klinikum rechts der Isar, Technische Universität München, Germany
| | - Tobias U. Hauser
- Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric Hospital, University of Zurich, Zurich, Switzerland.,Max Planck UCL Centre for Computational Psychiatry and Ageing Research, London, UK.,Wellcome Centre for Human Neuroimaging, University College London, London, UK
| | - Yoshiyuki Hirano
- Research Center for Child Mental Development, Chiba University, Chiba, Japan
| | - Marcelo Q. Hoexter
- Departamento e Instituto de Psiquiatria do Hospital das Clinicas, IPQ HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, SP, Brasil
| | - Hao Hu
- Shanghai Mental Health Center Shanghai Jiao Tong University School of Medicine, PR China
| | - Chaim Huyser
- De Bascule, Academic Center for Child and Adolescent Psychiatry, Amsterdam, the Netherlands.,Department of child and adolescent psychiatry Amsterdam UMC, Amsterdam, The Netherlands
| | - Anthony James
- Department of Psychiatry, Oxford University, Oxford, U.K
| | | | - Norbert Kathmann
- Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany
| | - Christian Kaufmann
- Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany
| | - Kathrin Koch
- Department of Neuroradiology, Klinikum rechts der Isar, Technische Universität München, Germany.,TUM-Neuroimaging Center (TUM-NIC) of Klinikum rechts der Isar, Technische Universität München, Germany
| | - Masaru Kuno
- Research Center for Child Mental Development, Chiba University, Chiba, Japan
| | - Gerd Kvale
- OCD-team, Haukeland University Hospital, Bergen, Norway.,Department of Clinical Psychology, University of Bergen, Bergen, Norway
| | - Jun Soo Kwon
- Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea.,Department of Brain & Cognitive Sciences, Seoul National University College of Natural Sciences, Seoul, Korea
| | - Luisa Lazaro
- Department of Child and Adolescent Psychiatry and Psychology, Institute of Neurosciences, Hospital Clínic Universitari, Barcelona, Spain.,Department of Medicine, University of Barcelona, Barcelona, Spain.,Centro de Investigación Biomédica en red de Salud Mental (CIBERSAM), Spain.,Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
| | - Yanni Liu
- Department of Psychiatry, University of Michigan, Ann Arbor, Michigan, U.S.A
| | - Christine Lochner
- SU/UCT MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, South Africa
| | - Paulo Marques
- Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal..,ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal..,Clinical Academic Center-Braga, Braga, Portugal
| | - Rachel Marsh
- Columbia University Irving Medical Center, Columbia University, New York, NY, U.S.A..,The Division of Child and Adolescent Psychiatry, New York State Psychiatric Institute, Columbia University, New York, NY, U.S.A
| | - Ignacio Martínez-Zalacaín
- Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain.,Department of Clinical Sciences, University of Barcelona, Spain
| | - David Mataix-Cols
- Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, Stockholm, Sweden
| | - Sarah E. Medland
- Psychiatric Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
| | - José M. Menchón
- Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain.,Centro de Investigación Biomèdica en Red de Salud Mental-CIBERSAM, Barcelona, Spain.,Department of Clinical Sciences, University of Barcelona, Spain
| | - Luciano Minuzzi
- Mood Disorders Clinic, St. Joseph’s HealthCare, Hamilton, Ontario, Canada
| | - Pedro S Moreira
- Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal..,ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal..,Clinical Academic Center-Braga, Braga, Portugal
| | - Astrid Morer
- Department of Child and Adolescent Psychiatry and Psychology, Institute of Neurosciences, Hospital Clínic Universitari, Barcelona, Spain.,Department of Medicine, University of Barcelona, Barcelona, Spain.,Centro de Investigación Biomédica en red de Salud Mental (CIBERSAM), Spain.,Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
| | - Pedro Morgado
- Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal..,ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal..,Clinical Academic Center-Braga, Braga, Portugal
| | - Akiko Nakagawa
- Research Center for Child Mental Development, Chiba University, Chiba, Japan
| | - Takashi Nakamae
- Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - Tomohiro Nakao
- Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
| | - Janardhanan. C. Narayanaswamy
- Obsessive-Compulsive Disorder (OCD) Clinic Department of Psychiatry National Institute of Mental Health & Neurosciences, Bangalore, India
| | - Erika L. Nurmi
- Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA, U.S.A
| | - Joseph O’Neil
- Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA, U.S.A
| | - Jose C. Pariente
- Magnetic Resonance Image Core Facility, IDIBAPS (Institut d’Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain
| | - Chris Perriello
- McLean Hospital, Harvard Medical School, Belmont, MA, U.S.A..,University of Illinois at Urbana-Champaign, Champaign, IL, U.S.A
| | - John Piacentini
- Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA, U.S.A
| | - Fabrizio Piras
- Laboratory of Neuropsychiatry, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy
| | - Federica Piras
- Laboratory of Neuropsychiatry, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy
| | - Christopher Pittenger
- Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, U.S.A
| | - Y.C. Janardhan Reddy
- Obsessive-Compulsive Disorder (OCD) Clinic Department of Psychiatry National Institute of Mental Health & Neurosciences, Bangalore, India
| | | | - Yuki Sakai
- Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.,ATR Brain Information Communication Research Laboratory Group, Kyoto, Japan
| | - Joao R. Sato
- Center of Mathematics, Computing and Cognition, Universidade Federal do ABC, Santo Andre, Brazil
| | - Lianne Schmaal
- Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, VIC, Australia.,Centre for Youth Mental Health, The University of Melbourne, Melbourne, VIC, Australia
| | - H. Blair Simpson
- Columbia University Irving Medical Center, Columbia University, New York, NY, U.S.A..,Center for OCD and Related Disorders, New York State Psychiatric Institute, New York, NY, U.S.A
| | - Noam Soreni
- Pediatric OCD Consultation service, Anxiety Treatment and Research Center, St. Joseph’s HealthCare, Hamilton, Ontario, Canada
| | - Carles Soriano-Mas
- Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain.,Centro de Investigación Biomèdica en Red de Salud Mental-CIBERSAM, Barcelona, Spain.,Department of Psychobiology and Methodology of Health Sciences, Universitat Autònoma de Barcelona, Spain
| | - Gianfranco Spalletta
- Laboratory of Neuropsychiatry, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy.,Beth K. and Stuart C. Yudofsky Division of Neuropsychiatry, Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, Texas, USA
| | - Emily R. Stern
- Department of Psychiatry, New York University School of Medicine, New York, NY, U.S.A..,Nathan Kline Institute for Psychiatric Research, Orangeburg, NY, U.S.A
| | - Michael C. Stevens
- Yale University School of Medicine, New Haven, Conneticut, U.S.A.,Clinical Neuroscience and Development Laboratory, Olin Neuropsychiatry Research Center, Hartford, Connecticut, U.S.A
| | - S. Evelyn Stewart
- Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.,Provincial Obsessive-Compulsive Disorder Program, British Columbia Children’s Hospital, Vancouver, BC, Canada
| | - Philip R. Szeszko
- Icahn School of Medicine at Mount Sinai, New York, U.S.A..,James J. Peters VA Medical Center, Bronx, New York, U.S.A
| | - David F. Tolin
- Institute of Living/Hartford Hospital, Hartford, Connecticut, USA.,Yale University School of Medicine, New Haven, Connecticut, U.S.A
| | - Aki Tsuchiyagaito
- Research Center for Child Mental Development, Chiba University, Chiba, Japan.,Laureate Institute for Brain Research, Tulsa, Oklahoma, U.S.A
| | - Daan van Rooij
- Department of Cognitive Neurosicence, Donders Institute for Brain, Cognition and Behavior, Radboudumc, Nijmegen, The Netherlands
| | - Guido A. van Wingen
- Amsterdam UMC, University of Amsterdam, Department of Psychiatry, Amsterdam Neuroscience, Amsterdam, Netherlands
| | - Ganesan Venkatasubramanian
- Obsessive-Compulsive Disorder (OCD) Clinic Department of Psychiatry National Institute of Mental Health & Neurosciences, Bangalore, India
| | - Zhen Wang
- Shanghai Mental Health Center Shanghai Jiao Tong University School of Medicine, PR China.,Shanghai Key Laboratory of Psychotic Disorders, PR China
| | - Je-Yeon Yun
- Seoul National University Hospital, Seoul, Republic of Korea.,Yeongeon Student Support Center, Seoul national University College of Medicine, Seoul, Republic of Korea
| | | | - Paul M. Thompson
- Imaging Genetics Center, Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of the University of Southern California, Marina del Rey, U.S.A
| | - Dan J. Stein
- SU/UCT MRC Unit on Risk & Resilience in Mental Disorders, Department of Psychiatry and Mental Health, University of Cape Town, South Africa
| | - Odile A. van den Heuvel
- Amsterdam UMC, Vrije Universteit Amsterdam, Department of Psychiatry, Amsterdam Neuroscience, Amsterdam, The Netherlands.,Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Anatomy & Neurosciences, Amsterdam Neuroscience, Amsterdam, The Netherlands
| | - Clyde Francks
- Language and Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen, The Netherlands; Donders Institute for Brain, Cognition and Behavior, Radboud University, Nijmegen, The Netherlands.
| |
Collapse
|
4
|
Yun JY, Boedhoe PSW, Vriend C, Jahanshad N, Abe Y, Ameis SH, Anticevic A, Arnold PD, Batistuzzo MC, Benedetti F, Beucke JC, Bollettini I, Bose A, Brem S, Calvo A, Cheng Y, Cho KIK, Ciullo V, Dallaspezia S, Denys D, Feusner JD, Fouche JP, Giménez M, Gruner P, Hibar DP, Hoexter MQ, Hu H, Huyser C, Ikari K, Kathmann N, Kaufmann C, Koch K, Lazaro L, Lochner C, Marques P, Marsh R, Martínez-Zalacaín I, Mataix-Cols D, Menchón JM, Minuzzi L, Morgado P, Moreira P, Nakamae T, Nakao T, Narayanaswamy JC, Nurmi EL, O'Neill J, Piacentini J, Piras F, Piras F, Reddy YCJ, Sato JR, Simpson HB, Soreni N, Soriano-Mas C, Spalletta G, Stevens MC, Szeszko PR, Tolin DF, Venkatasubramanian G, Walitza S, Wang Z, van Wingen GA, Xu J, Xu X, Zhao Q, Thompson PM, Stein DJ, van den Heuvel OA, Kwon JS. Brain structural covariance networks in obsessive-compulsive disorder: a graph analysis from the ENIGMA Consortium. Brain 2020; 143:684-700. [PMID: 32040561 PMCID: PMC7009583 DOI: 10.1093/brain/awaa001] [Citation(s) in RCA: 37] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2019] [Revised: 11/24/2019] [Accepted: 11/26/2019] [Indexed: 12/13/2022] Open
Abstract
Brain structural covariance networks reflect covariation in morphology of different brain areas and are thought to reflect common trajectories in brain development and maturation. Large-scale investigation of structural covariance networks in obsessive-compulsive disorder (OCD) may provide clues to the pathophysiology of this neurodevelopmental disorder. Using T1-weighted MRI scans acquired from 1616 individuals with OCD and 1463 healthy controls across 37 datasets participating in the ENIGMA-OCD Working Group, we calculated intra-individual brain structural covariance networks (using the bilaterally-averaged values of 33 cortical surface areas, 33 cortical thickness values, and six subcortical volumes), in which edge weights were proportional to the similarity between two brain morphological features in terms of deviation from healthy controls (i.e. z-score transformed). Global networks were characterized using measures of network segregation (clustering and modularity), network integration (global efficiency), and their balance (small-worldness), and their community membership was assessed. Hub profiling of regional networks was undertaken using measures of betweenness, closeness, and eigenvector centrality. Individually calculated network measures were integrated across the 37 datasets using a meta-analytical approach. These network measures were summated across the network density range of K = 0.10-0.25 per participant, and were integrated across the 37 datasets using a meta-analytical approach. Compared with healthy controls, at a global level, the structural covariance networks of OCD showed lower clustering (P < 0.0001), lower modularity (P < 0.0001), and lower small-worldness (P = 0.017). Detection of community membership emphasized lower network segregation in OCD compared to healthy controls. At the regional level, there were lower (rank-transformed) centrality values in OCD for volume of caudate nucleus and thalamus, and surface area of paracentral cortex, indicative of altered distribution of brain hubs. Centrality of cingulate and orbito-frontal as well as other brain areas was associated with OCD illness duration, suggesting greater involvement of these brain areas with illness chronicity. In summary, the findings of this study, the largest brain structural covariance study of OCD to date, point to a less segregated organization of structural covariance networks in OCD, and reorganization of brain hubs. The segregation findings suggest a possible signature of altered brain morphometry in OCD, while the hub findings point to OCD-related alterations in trajectories of brain development and maturation, particularly in cingulate and orbitofrontal regions.
Collapse
Affiliation(s)
- Je-Yeon Yun
- Seoul National University Hospital, Seoul, Republic of Korea
- Yeongeon Student Support Center, Seoul National University College of Medicine, Seoul, Republic of Korea
| | - Premika S W Boedhoe
- Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Psychiatry, Amsterdam Neuroscience, Amsterdam, The Netherlands
- Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Anatomy & Neurosciences, Amsterdam Neuroscience, Amsterdam, The Netherlands
| | - Chris Vriend
- Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Psychiatry, Amsterdam Neuroscience, Amsterdam, The Netherlands
- Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Anatomy & Neurosciences, Amsterdam Neuroscience, Amsterdam, The Netherlands
| | - Neda Jahanshad
- Imaging Genetics Center, Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of the University of Southern California, Marina del Rey, CA, USA
| | - Yoshinari Abe
- Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - Stephanie H Ameis
- The Margaret and Wallace McCain Centre for Child, Youth & Family Mental Health, Campbell Family Mental Health Research Institute, The Centre for Addiction and Mental Health, Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Canada
- Centre for Brain and Mental Health, The Hospital for Sick Children, Toronto, Canada
| | - Alan Anticevic
- Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA
| | - Paul D Arnold
- Mathison Centre for Mental Health Research and Education, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
- Department of Psychiatry, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
| | - Marcelo C Batistuzzo
- Departamento e Instituto de Psiquiatria do Hospital das Clinicas, IPQ HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, SP, Brazil
| | - Francesco Benedetti
- Psychiatry and Clinical Psychobiology, Division of Neuroscience, Scientific Institute Ospedale San Raffaele, Milano, Italy
| | - Jan C Beucke
- Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany
| | - Irene Bollettini
- Psychiatry and Clinical Psychobiology, Division of Neuroscience, Scientific Institute Ospedale San Raffaele, Milano, Italy
| | - Anushree Bose
- Obsessive-Compulsive Disorder (OCD) Clinic Department of Psychiatry National Institute of Mental Health and Neurosciences, Bangalore, India
| | - Silvia Brem
- Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric Hospital, University of Zurich, Zurich, Switzerland
| | - Anna Calvo
- Magnetic Resonance Image Core Facility, IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain
| | - Yuqi Cheng
- Department of Psychiatry, First Affiliated Hospital of Kunming Medical University, Kunming, China
| | - Kang Ik K Cho
- Institute of Human Behavioral Medicine, SNU-MRC, Seoul, Republic of Korea
| | - Valentina Ciullo
- Laboratory of Neuropsychiatry, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy
| | - Sara Dallaspezia
- Psychiatry and Clinical Psychobiology, Division of Neuroscience, Scientific Institute Ospedale San Raffaele, Milano, Italy
| | - Damiaan Denys
- Amsterdam UMC, University of Amsterdam, Department of Psychiatry, Amsterdam Neuroscience, Amsterdam, The Netherlands
- Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences, Amsterdam, The Netherlands
| | - Jamie D Feusner
- Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA
| | - Jean-Paul Fouche
- SAMRC Unit on Risk and Resilience in Mental Disorders, Department of Psychiatry, University of Cape Town, Cape Town, South Africa
| | - Mònica Giménez
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Carlos III Health Institute, Barcelona, Spain
- Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain
| | - Patricia Gruner
- Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA
| | - Derrek P Hibar
- Imaging Genetics Center, Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of the University of Southern California, Marina del Rey, CA, USA
| | - Marcelo Q Hoexter
- Departamento e Instituto de Psiquiatria do Hospital das Clinicas, IPQ HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, SP, Brazil
| | - Hao Hu
- Shanghai Mental Health Center Shanghai Jiao Tong University School of Medicine, PR China
| | - Chaim Huyser
- De Bascule, Academic Center for Child and Adolescent Psychiatry, Amsterdam, The Netherlands
- Amsterdam UMC, Department of Child and Adolescent Psychiatry, Amsterdam, The Netherlands
| | - Keisuke Ikari
- Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi Higashi-ku, Fukuoka, Japan
| | - Norbert Kathmann
- Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany
| | - Christian Kaufmann
- Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany
| | - Kathrin Koch
- Department of Neuroradiology, Klinikum rechts der Isar, Technische Universität München, Germany
- TUM-Neuroimaging Center (TUM-NIC) of Klinikum rechts der Isar, Technische Universität München, Germany
| | - Luisa Lazaro
- Department of Child and Adolescent Psychiatry and Psychology, Institute of Neurosciences, Hospital Clínic Universitari, Barcelona, Spain
- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Department of Medicine, University of Barcelona, Barcelona, Spain
- Centro de Investigación Biomèdica en Red de Salud Mental (CIBERSAM), Barcelona, Spain
| | - Christine Lochner
- SAMRC Unit on Anxiety and Stress Disorders, Department of Psychiatry, University of Stellenbosch, South Africa
| | - Paulo Marques
- Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal
| | - Rachel Marsh
- Columbia University Medical College, Columbia University, New York, NY, USA
- The New York State Psychiatric Institute, New York, NY, USA
| | - Ignacio Martínez-Zalacaín
- Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain
- Department of Clinical Sciences, University of Barcelona, Spain
| | - David Mataix-Cols
- Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, Stockholm, Sweden
| | - José M Menchón
- Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain
- Centro de Investigación Biomèdica en Red de Salud Mental (CIBERSAM), Barcelona, Spain
- Department of Clinical Sciences, University of Barcelona, Spain
| | - Luciano Minuzzi
- McMaster University, Department of Psychiatry and Behavioural Neurosciences, Hamilton, Ontario, Canada
| | - Pedro Morgado
- Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal
- Clinical Academic Center-Braga, Braga, Portugal
- ICVS-3Bs PT Government Associate Laboratory, Braga, Portugal
| | - Pedro Moreira
- Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal
- Clinical Academic Center-Braga, Braga, Portugal
- ICVS-3Bs PT Government Associate Laboratory, Braga, Portugal
| | - Takashi Nakamae
- Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - Tomohiro Nakao
- Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
| | - Janardhanan C Narayanaswamy
- Obsessive-Compulsive Disorder (OCD) Clinic Department of Psychiatry National Institute of Mental Health and Neurosciences, Bangalore, India
| | - Erika L Nurmi
- Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA
| | - Joseph O'Neill
- Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA
- Division of Child and Adolescent Psychiatry, University of California, Los Angeles, CA, USA
| | - John Piacentini
- Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA
- Division of Child and Adolescent Psychiatry, University of California, Los Angeles, CA, USA
| | - Fabrizio Piras
- Laboratory of Neuropsychiatry, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy
| | - Federica Piras
- Laboratory of Neuropsychiatry, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy
| | - Y C Janardhan Reddy
- Obsessive-Compulsive Disorder (OCD) Clinic Department of Psychiatry National Institute of Mental Health and Neurosciences, Bangalore, India
| | - Joao R Sato
- Center for Mathematics, Computing and Cognition, Universidade Federal do ABC, Santo Andre, Brazil
| | - H Blair Simpson
- Columbia University Medical College, Columbia University, New York, NY, USA
- Center for OCD and Related Disorders, New York State Psychiatric Institute, New York, NY, USA
| | - Noam Soreni
- Pediatric OCD Consultation Service, Anxiety Treatment and Research Center, St. Joseph's HealthCare, Hamilton, Ontario, Canada
| | - Carles Soriano-Mas
- Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain
- Centro de Investigación Biomèdica en Red de Salud Mental (CIBERSAM), Barcelona, Spain
- Department of Psychobiology and Methodology of Health Sciences, Universitat Autònoma de Barcelona, Spain
| | - Gianfranco Spalletta
- Laboratory of Neuropsychiatry, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy
- Beth K. and Stuart C. Yudofsky Division of Neuropsychiatry, Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, Texas, USA
| | - Michael C Stevens
- Yale University School of Medicine, New Haven, Connecticut, USA
- Clinical Neuroscience and Development Laboratory, Olin Neuropsychiatry Research Center, Hartford, Connecticut, USA
| | - Philip R Szeszko
- Icahn School of Medicine at Mount Sinai, New York, USA
- James J. Peters VA Medical Center, Bronx, New York, USA
| | - David F Tolin
- Yale University School of Medicine, New Haven, Connecticut, USA
- Institute of Living/Hartford Hospital, Hartford, Connecticut, USA
| | - Ganesan Venkatasubramanian
- Obsessive-Compulsive Disorder (OCD) Clinic Department of Psychiatry National Institute of Mental Health and Neurosciences, Bangalore, India
| | - Susanne Walitza
- Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric Hospital, University of Zurich, Zurich, Switzerland
| | - Zhen Wang
- Shanghai Mental Health Center Shanghai Jiao Tong University School of Medicine, PR China
- Shanghai Key Laboratory of Psychotic Disorders, PR China
| | - Guido A van Wingen
- Amsterdam UMC, University of Amsterdam, Department of Psychiatry, Amsterdam Neuroscience, Amsterdam, The Netherlands
| | - Jian Xu
- Department of Psychiatry, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, PR China
| | - Xiufeng Xu
- Department of Psychiatry, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, PR China
| | - Qing Zhao
- Shanghai Mental Health Center Shanghai Jiao Tong University School of Medicine, PR China
| | - Paul M Thompson
- Imaging Genetics Center, Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of the University of Southern California, Marina del Rey, CA, USA
| | - Dan J Stein
- SAMRC Unit on Risk and Resilience in Mental Disorders, Department of Psychiatry, University of Cape Town, Cape Town, South Africa
| | - Odile A van den Heuvel
- Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Psychiatry, Amsterdam Neuroscience, Amsterdam, The Netherlands
- Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Anatomy & Neurosciences, Amsterdam Neuroscience, Amsterdam, The Netherlands
| | - Jun Soo Kwon
- Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea
- Department of Brain and Cognitive Sciences, Seoul National University College of Natural Sciences, Seoul, Republic of Korea
| |
Collapse
|
5
|
Bueno APA, Sato JR, Hornberger M. Eye tracking - The overlooked method to measure cognition in neurodegeneration? Neuropsychologia 2019; 133:107191. [PMID: 31521634 DOI: 10.1016/j.neuropsychologia.2019.107191] [Citation(s) in RCA: 26] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2019] [Revised: 08/26/2019] [Accepted: 09/08/2019] [Indexed: 12/11/2022]
Abstract
Eye tracking (ET) studies are becoming increasingly popular due to rapid methodological and technological advances as well as the development of cost efficient and portable eye trackers. Although historically ET has been mostly employed in psychophysics or developmental cognition studies, there is also promising scope to use ET for movement disorders and measuring cognitive processes in neurodegeneration. Particularly, ET can be a powerful tool for cognitive and neuropsychological assessments of patients with pathologies affecting motor and verbal abilities, as tasks can be adapted without requiring motor (except eye movements) or verbal responses. In this review, we will examine the existing evidence of ET methods in neurodegenerative conditions and its potential clinical impact for cognitive assessment. We highlight that current evidence for ET is mostly focused on diagnostics of cognitive impairments in neurodegenerative disorders, where it is debatable whether it has any more sensitivity or specificity than existing cognitive assessments. By contrast, there is currently a lack of ET studies in more advanced disease stages, when patients' motor and verbal functions can be significantly affected, and standard cognitive assessments are challenging or often not possible. We conclude that ET is a promising method not only for cognitive diagnostics but more importantly, for potential cognitive disease tracking in progressive neurodegenerative conditions.
Collapse
Affiliation(s)
- A P A Bueno
- - Center of Mathematics, Computing and Cognition, Universidade Federal do ABC, Santo André, Brazil; - Department of Medicine, Norwich Medical School, University of East Anglia, Norwich, UK.
| | - J R Sato
- - Center of Mathematics, Computing and Cognition, Universidade Federal do ABC, Santo André, Brazil
| | - M Hornberger
- - Department of Medicine, Norwich Medical School, University of East Anglia, Norwich, UK; - Norfolk and Suffolk NHS Foundation Trust, Norwich, UK
| |
Collapse
|
6
|
Boedhoe PSW, Heymans MW, Schmaal L, Abe Y, Alonso P, Ameis SH, Anticevic A, Arnold PD, Batistuzzo MC, Benedetti F, Beucke JC, Bollettini I, Bose A, Brem S, Calvo A, Calvo R, Cheng Y, Cho KIK, Ciullo V, Dallaspezia S, Denys D, Feusner JD, Fitzgerald KD, Fouche JP, Fridgeirsson EA, Gruner P, Hanna GL, Hibar DP, Hoexter MQ, Hu H, Huyser C, Jahanshad N, James A, Kathmann N, Kaufmann C, Koch K, Kwon JS, Lazaro L, Lochner C, Marsh R, Martínez-Zalacaín I, Mataix-Cols D, Menchón JM, Minuzzi L, Morer A, Nakamae T, Nakao T, Narayanaswamy JC, Nishida S, Nurmi EL, O'Neill J, Piacentini J, Piras F, Piras F, Reddy YCJ, Reess TJ, Sakai Y, Sato JR, Simpson HB, Soreni N, Soriano-Mas C, Spalletta G, Stevens MC, Szeszko PR, Tolin DF, van Wingen GA, Venkatasubramanian G, Walitza S, Wang Z, Yun JY, Thompson PM, Stein DJ, van den Heuvel OA, Twisk JWR. An Empirical Comparison of Meta- and Mega-Analysis With Data From the ENIGMA Obsessive-Compulsive Disorder Working Group. Front Neuroinform 2019; 12:102. [PMID: 30670959 PMCID: PMC6331928 DOI: 10.3389/fninf.2018.00102] [Citation(s) in RCA: 47] [Impact Index Per Article: 9.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2018] [Accepted: 12/13/2018] [Indexed: 01/08/2023] Open
Abstract
Objective: Brain imaging communities focusing on different diseases have increasingly started to collaborate and to pool data to perform well-powered meta- and mega-analyses. Some methodologists claim that a one-stage individual-participant data (IPD) mega-analysis can be superior to a two-stage aggregated data meta-analysis, since more detailed computations can be performed in a mega-analysis. Before definitive conclusions regarding the performance of either method can be drawn, it is necessary to critically evaluate the methodology of, and results obtained by, meta- and mega-analyses. Methods: Here, we compare the inverse variance weighted random-effect meta-analysis model with a multiple linear regression mega-analysis model, as well as with a linear mixed-effects random-intercept mega-analysis model, using data from 38 cohorts including 3,665 participants of the ENIGMA-OCD consortium. We assessed the effect sizes and standard errors, and the fit of the models, to evaluate the performance of the different methods. Results: The mega-analytical models showed lower standard errors and narrower confidence intervals than the meta-analysis. Similar standard errors and confidence intervals were found for the linear regression and linear mixed-effects random-intercept models. Moreover, the linear mixed-effects random-intercept models showed better fit indices compared to linear regression mega-analytical models. Conclusions: Our findings indicate that results obtained by meta- and mega-analysis differ, in favor of the latter. In multi-center studies with a moderate amount of variation between cohorts, a linear mixed-effects random-intercept mega-analytical framework appears to be the better approach to investigate structural neuroimaging data.
Collapse
Affiliation(s)
- Premika S W Boedhoe
- Department of Psychiatry, Amsterdam University Medical Centers (UMC), Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam, Netherlands.,Department of Anatomy and Neurosciences, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam, Netherlands
| | - Martijn W Heymans
- Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
| | - Lianne Schmaal
- Orygen, The National Centre of Excellence in Youth Mental Health, Melbourne, VIC, Australia.,Centre for Youth Mental Health, The University of Melbourne, Melbourne, VIC, Australia
| | - Yoshinari Abe
- Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - Pino Alonso
- Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.,Centro de Investigación Biomèdica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.,Department of Clinical Sciences, University of Barcelona, Barcelona, Spain
| | - Stephanie H Ameis
- Department of Psychiatry, Faculty of Medicine, The Centre for Addiction and Mental Health, The Margaret and Wallace McCain Centre for Child, Youth and Family Mental Health, Campbell Family Mental Health Research Institute, University of Toronto, Toronto, ON, Canada.,The Hospital for Sick Children, Centre for Brain and Mental Health, Toronto, ON, Canada
| | - Alan Anticevic
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States
| | - Paul D Arnold
- Mathison Centre for Mental Health Research and Education, Cumming School of Medicine, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.,Department of Psychiatry, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
| | - Marcelo C Batistuzzo
- Departamento de Psiquiatria, Faculdade de Medicina, Instituto de Psiquiatria, Universidade de São Paulo, São Paulo, Brazil
| | - Francesco Benedetti
- Division of Neuroscience, Psychiatry and Clinical Psychobiology, Scientific Institute Ospedale San Raffaele, Milan, Italy
| | - Jan C Beucke
- Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany
| | - Irene Bollettini
- Division of Neuroscience, Psychiatry and Clinical Psychobiology, Scientific Institute Ospedale San Raffaele, Milan, Italy
| | - Anushree Bose
- Obsessive-Compulsive Disorder (OCD) Clinic Department of Psychiatry National Institute of Mental Health and Neurosciences, Bangalore, India
| | - Silvia Brem
- Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric Hospital, University of Zurich, Zurich, Switzerland
| | - Anna Calvo
- Magnetic Resonance Image Core Facility, IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain
| | - Rosa Calvo
- Centro de Investigación Biomèdica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.,Department of Child and Adolescent Psychiatry and Psychology, Hospital Clínic Universitari, Institute of Neurosciences, Barcelona, Spain
| | - Yuqi Cheng
- Department of Psychiatry, First Affiliated Hospital of Kunming Medical University, Kunming, China
| | - Kang Ik K Cho
- Institute of Human Behavioral Medicine, SNU-MRC, Seoul, South Korea
| | - Valentina Ciullo
- Laboratory of Neuropsychiatry, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy.,Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy
| | - Sara Dallaspezia
- Division of Neuroscience, Psychiatry and Clinical Psychobiology, Scientific Institute Ospedale San Raffaele, Milan, Italy
| | - Damiaan Denys
- Department of Psychiatry, Amsterdam Neuroscience, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands.,Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences, Amsterdam, Netherlands
| | - Jamie D Feusner
- Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA, United States
| | - Kate D Fitzgerald
- Department of Psychiatry, University of Michigan, Ann Arbor, MI, United States
| | - Jean-Paul Fouche
- MRC Unit on Risk & Resilience in Mental Disorders, Department of Psychiatry, University of Cape Town, Cape Town, South Africa
| | - Egill A Fridgeirsson
- Department of Psychiatry, Amsterdam Neuroscience, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands
| | - Patricia Gruner
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States
| | - Gregory L Hanna
- Department of Psychiatry, University of Michigan, Ann Arbor, MI, United States
| | - Derrek P Hibar
- Imaging Genetics Center, Keck School of Medicine of the University of Southern California, Mark and Mary Stevens Neuroimaging and Informatics Institute, Marina del Rey, CA, United States
| | - Marcelo Q Hoexter
- Departamento de Psiquiatria, Faculdade de Medicina, Instituto de Psiquiatria, Universidade de São Paulo, São Paulo, Brazil
| | - Hao Hu
- Shanghai Mental Health Center Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Chaim Huyser
- De Bascule, Academic Center for Child and Adolescent Psychiatry, Amsterdam, Netherlands.,Department of Child and Adolescent Psychiatry, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands
| | - Neda Jahanshad
- Yeongeon Student Support Center, Seoul National University College of Medicine, Seoul, South Korea
| | - Anthony James
- Department of Psychiatry, Oxford University, Oxford, United Kingdom
| | - Norbert Kathmann
- Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany
| | - Christian Kaufmann
- Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany
| | - Kathrin Koch
- Department of Neuroradiology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.,TUM-Neuroimaging Center (TUM-NIC) of Klinikum rechts der Isar, Technische Universität München, Munich, Germany
| | - Jun Soo Kwon
- Department of Psychiatry, Seoul National University College of Medicine, Seoul, South Korea.,Department of Brain and Cognitive Sciences, Seoul National University College of Natural Sciences, Seoul, South Korea
| | - Luisa Lazaro
- Centro de Investigación Biomèdica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.,Department of Child and Adolescent Psychiatry and Psychology, Hospital Clínic Universitari, Institute of Neurosciences, Barcelona, Spain.,Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.,Department of Medicine, University of Barcelona, Barcelona, Spain
| | - Christine Lochner
- SU/UCT MRC Unit on Anxiety and Stress Disorders, Department of Psychiatry, University of Stellenbosch, Stellenbosch, South Africa
| | - Rachel Marsh
- Columbia University Medical College, Columbia University, New York, NY, United States.,The New York State Psychiatric Institute, New York, NY, United States
| | - Ignacio Martínez-Zalacaín
- Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain
| | - David Mataix-Cols
- Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, Stockholm, Sweden
| | - José M Menchón
- Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.,Centro de Investigación Biomèdica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.,Department of Clinical Sciences, University of Barcelona, Barcelona, Spain
| | - Luciano Minuzzi
- Mood Disorders Clinic, St. Joseph's HealthCare, Hamilton, ON, Canada
| | - Astrid Morer
- Centro de Investigación Biomèdica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.,Department of Child and Adolescent Psychiatry and Psychology, Hospital Clínic Universitari, Institute of Neurosciences, Barcelona, Spain.,Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
| | - Takashi Nakamae
- Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - Tomohiro Nakao
- Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
| | - Janardhanan C Narayanaswamy
- Obsessive-Compulsive Disorder (OCD) Clinic Department of Psychiatry National Institute of Mental Health and Neurosciences, Bangalore, India
| | - Seiji Nishida
- Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - Erika L Nurmi
- Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA, United States
| | - Joseph O'Neill
- Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA, United States
| | - John Piacentini
- Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA, United States
| | - Fabrizio Piras
- Laboratory of Neuropsychiatry, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy
| | - Federica Piras
- Laboratory of Neuropsychiatry, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy
| | - Y C Janardhan Reddy
- Obsessive-Compulsive Disorder (OCD) Clinic Department of Psychiatry National Institute of Mental Health and Neurosciences, Bangalore, India
| | - Tim J Reess
- Department of Neuroradiology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.,TUM-Neuroimaging Center (TUM-NIC) of Klinikum rechts der Isar, Technische Universität München, Munich, Germany
| | - Yuki Sakai
- Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.,ATR Brain Information Communication Research Laboratory Group, Kyoto, Japan
| | - Joao R Sato
- Center for Mathematics, Computing and Cognition, Universidade Federal do ABC, Santo Andre, Brazil
| | - H Blair Simpson
- Columbia University Medical College, Columbia University, New York, NY, United States.,Center for OCD and Related Disorders, New York State Psychiatric Institute, New York, NY, United States
| | - Noam Soreni
- Anxiety Treatment and Research Center, St. Joseph's HealthCare, Hamilton, ON, Canada
| | - Carles Soriano-Mas
- Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.,Centro de Investigación Biomèdica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.,Department of Psychobiology and Methodology of Health Sciences, Universitat Autònoma de Barcelona, Barcelona, Spain
| | - Gianfranco Spalletta
- Laboratory of Neuropsychiatry, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy.,Beth K. and Stuart C. Yudofsky Division of Neuropsychiatry, Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, United States
| | - Michael C Stevens
- Yale University School of Medicine, New Haven, CT, United States.,Clinical Neuroscience and Development Laboratory, Olin Neuropsychiatry Research Center, Hartford, CT, United States
| | - Philip R Szeszko
- Icahn School of Medicine at Mount Sinai, New York, NY, United States.,James J. Peters VA Medical Center, Bronx, NY, United States
| | - David F Tolin
- Yale University School of Medicine, New Haven, CT, United States.,Institute of Living/Hartford Hospital, Hartford, CT, United States
| | - Guido A van Wingen
- Department of Psychiatry, Amsterdam Neuroscience, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands
| | - Ganesan Venkatasubramanian
- Obsessive-Compulsive Disorder (OCD) Clinic Department of Psychiatry National Institute of Mental Health and Neurosciences, Bangalore, India
| | - Susanne Walitza
- Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric Hospital, University of Zurich, Zurich, Switzerland
| | - Zhen Wang
- Shanghai Mental Health Center Shanghai Jiao Tong University School of Medicine, Shanghai, China.,Shanghai Key Laboratory of Psychotic Disorders, Shanghai, China
| | - Je-Yeon Yun
- Yeongeon Student Support Center, Seoul National University College of Medicine, Seoul, South Korea.,Department of Psychiatry, Seoul National University College of Medicine, Seoul, South Korea
| | | | - Paul M Thompson
- Imaging Genetics Center, Keck School of Medicine of the University of Southern California, Mark and Mary Stevens Neuroimaging and Informatics Institute, Marina del Rey, CA, United States
| | - Dan J Stein
- MRC Unit on Risk & Resilience in Mental Disorders, Department of Psychiatry, University of Cape Town, Cape Town, South Africa
| | - Odile A van den Heuvel
- Department of Psychiatry, Amsterdam University Medical Centers (UMC), Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam, Netherlands.,Department of Anatomy and Neurosciences, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam, Netherlands
| | - Jos W R Twisk
- Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
| |
Collapse
|
7
|
Brockington G, Balardin JB, Zimeo Morais GA, Malheiros A, Lent R, Moura LM, Sato JR. From the Laboratory to the Classroom: The Potential of Functional Near-Infrared Spectroscopy in Educational Neuroscience. Front Psychol 2018; 9:1840. [PMID: 30364351 PMCID: PMC6193429 DOI: 10.3389/fpsyg.2018.01840] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2018] [Accepted: 09/10/2018] [Indexed: 11/13/2022] Open
Abstract
Paralleling two decades of growth in the emergent field known as educational neuroscience is an increasing concern that educational practices and programs should be evidence-based, however, the idea that neuroscience could potentially influence education is controversial. One of the criticisms, regarding applications of the findings produced in this discipline, concerns the artificiality of neuroscientific experiments and the oversimplified nature of the tests used to investigate cognitive processes in educational contexts. The simulations may not account for all of the variables present in real classroom activities. In this study, we aim to get a step closer to the formation of data-supported classroom methodologies by employing functional near-infrared spectroscopy in various experimental paradigms. First, we present two hyperscanning scenarios designed to explore realistic interdisciplinary contexts, i.e., the classroom. In a third paradigm, we present a case study of a single student evaluated with functional near-infrared spectroscopy and mobile eye-tracking glasses. These three experiments are performed to provide proofs of concept for the application of functional near-infrared spectroscopy in scenarios that more closely resemble authentic classroom routines and daily activities. The goal of our study is to explore the potential of this technique in hopes that it offers insights in experimental design to investigate teaching-learning processes during teacher-student interactions.
Collapse
Affiliation(s)
- Guilherme Brockington
- Center for Natural and Human Sciences, Universidade Federal do ABC, Santo André, Brazil
- National Network of Science for Education, Rio de Janeiro, Brazil
| | | | | | - Amanda Malheiros
- Departamento de Ciências Exatas e da Terra, Universidade Federal de São Paulo, Diadema, Brazil
| | - Roberto Lent
- National Network of Science for Education, Rio de Janeiro, Brazil
- Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
- D'Or Institute of Research and Education, Rio de Janeiro, Brazil
| | - Luciana Monteiro Moura
- Center of Mathematics Computing and Cognition, Universidade Federal do ABC, São Bernardo do Campo, Brazil
| | - Joao R. Sato
- National Network of Science for Education, Rio de Janeiro, Brazil
- Center of Mathematics Computing and Cognition, Universidade Federal do ABC, São Bernardo do Campo, Brazil
| |
Collapse
|
8
|
Giménez M, Guinea-Izquierdo A, Villalta-Gil V, Martínez-Zalacaín I, Segalàs C, Subirà M, Real E, Pujol J, Harrison BJ, Haro JM, Sato JR, Hoexter MQ, Cardoner N, Alonso P, Menchón JM, Soriano-Mas C. Brain alterations in low-frequency fluctuations across multiple bands in obsessive compulsive disorder. Brain Imaging Behav 2018; 11:1690-1706. [PMID: 27771857 DOI: 10.1007/s11682-016-9601-y] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
The extent of functional abnormalities in frontal-subcortical circuits in obsessive-compulsive disorder (OCD) is still unclear. Although neuroimaging studies, in general, and resting-state functional Magnetic Resonance Imaging (rs-fMRI), in particular, have provided relevant information regarding such alterations, rs-fMRI studies have been typically limited to the analysis of between-region functional connectivity alterations at low-frequency signal fluctuations (i.e., <0.08 Hz). Conversely, the local attributes of Blood Oxygen Level Dependent (BOLD) signal across different frequency bands have been seldom studied, although they may provide valuable information. Here, we evaluated local alterations in low-frequency fluctuations across different oscillation bands in OCD. Sixty-five OCD patients and 50 healthy controls underwent an rs-fMRI assessment. Alterations in the fractional amplitude of low-frequency fluctuations (fALFF) were evaluated, voxel-wise, across four different bands (from 0.01 Hz to 0.25 Hz). OCD patients showed decreased fALFF values in medial orbitofrontal regions and increased fALFF values in the dorsal-medial prefrontal cortex (DMPFC) at frequency bands <0.08 Hz. This pattern was reversed at higher frequencies, where increased fALFF values also appeared in medial temporal lobe structures and medial thalamus. Clinical variables (i.e., symptom-specific severities) were associated with fALFF values across the different frequency bands. Our findings provide novel evidence about the nature and regional distribution of functional alterations in OCD, which should contribute to refine neurobiological models of the disorder. We suggest that the evaluation of the local attributes of BOLD signal across different frequency bands may be a sensitive approach to further characterize brain functional alterations in psychiatric disorders.
Collapse
Affiliation(s)
- Mònica Giménez
- Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), Feixa Llarga s/n, 08907, L'Hospitalet de Llobregat, Barcelona, Spain.,Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Carlos III Health Institute, Barcelona, Spain
| | - Andrés Guinea-Izquierdo
- Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), Feixa Llarga s/n, 08907, L'Hospitalet de Llobregat, Barcelona, Spain.,Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Carlos III Health Institute, Barcelona, Spain.,Department of Clinical Sciences, School of Medicine, University of Barcelona, 08907, Barcelona, Spain
| | - Victoria Villalta-Gil
- Research Unit, Parc Sanitari Sant Joan de Déu, Fundació Sant Joan de Déu, University of Barcelona, 08950, Sant Boi de Llobregat, Barcelona, Spain.,Affective Neuroscience Laboratory, Department of Psychology, Vanderbilt University, Nashville, TN, 37240, USA
| | - Ignacio Martínez-Zalacaín
- Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), Feixa Llarga s/n, 08907, L'Hospitalet de Llobregat, Barcelona, Spain
| | - Cinto Segalàs
- Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), Feixa Llarga s/n, 08907, L'Hospitalet de Llobregat, Barcelona, Spain.,Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Carlos III Health Institute, Barcelona, Spain
| | - Marta Subirà
- Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), Feixa Llarga s/n, 08907, L'Hospitalet de Llobregat, Barcelona, Spain.,Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Carlos III Health Institute, Barcelona, Spain.,Department of Clinical Sciences, School of Medicine, University of Barcelona, 08907, Barcelona, Spain
| | - Eva Real
- Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), Feixa Llarga s/n, 08907, L'Hospitalet de Llobregat, Barcelona, Spain.,Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Carlos III Health Institute, Barcelona, Spain
| | - Jesús Pujol
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Carlos III Health Institute, Barcelona, Spain.,MRI Research Unit, Department of Radiology, Hospital del Mar, 08003, Barcelona, Spain
| | - Ben J Harrison
- Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne, Melbourne, 3010, Australia
| | - Josep Maria Haro
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Carlos III Health Institute, Barcelona, Spain.,Research Unit, Parc Sanitari Sant Joan de Déu, Fundació Sant Joan de Déu, University of Barcelona, 08950, Sant Boi de Llobregat, Barcelona, Spain
| | - Joao R Sato
- Center of Mathematics, Computation and Cognition, Universidade Federal do ABC, Santo André, 5001, Brazil
| | - Marcelo Q Hoexter
- Department and Institute of Psychiatry, University of São Paulo Medical School, São Paulo, 05403-903, Brazil
| | - Narcís Cardoner
- Depression and Anxiety Program, Department of Mental Health, Parc Taulí Sabadell, Hospital Universitari, 08208, Sabadell, Barcelona, Spain.,Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, 08193, Cerdanyola, Barcelona, Spain
| | - Pino Alonso
- Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), Feixa Llarga s/n, 08907, L'Hospitalet de Llobregat, Barcelona, Spain.,Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Carlos III Health Institute, Barcelona, Spain.,Department of Clinical Sciences, School of Medicine, University of Barcelona, 08907, Barcelona, Spain
| | - José Manuel Menchón
- Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), Feixa Llarga s/n, 08907, L'Hospitalet de Llobregat, Barcelona, Spain.,Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Carlos III Health Institute, Barcelona, Spain.,Department of Clinical Sciences, School of Medicine, University of Barcelona, 08907, Barcelona, Spain
| | - Carles Soriano-Mas
- Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), Feixa Llarga s/n, 08907, L'Hospitalet de Llobregat, Barcelona, Spain. .,Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Carlos III Health Institute, Barcelona, Spain. .,Department of Psychobiology and Methodology of Health Sciences, Universitat Autònoma de Barcelona, 08193, Cerdanyola, Barcelona, Spain.
| |
Collapse
|
9
|
Boedhoe PS, Schmaal L, Abe Y, Alonso P, Ameis SH, Anticevic A, Arnold PD, Batistuzzo MC, Benedetti F, Beucke JC, Bollettini I, Bose A, Brem S, Calvo A, Calvo R, Cheng Y, Cho KIK, Ciullo V, Dallaspezia S, Denys D, Feusner JD, Fitzgerald KD, Fouche JP, Fridgeirsson EA, Gruner P, Hanna GL, Hibar DP, Hoexter MQ, Hu H, Huyser C, Jahanshad N, James A, Kathmann N, Kaufmann C, Koch K, Kwon JS, Lazaro L, Lochner C, Marsh R, Martínez-Zalacaín I, Mataix-Cols D, Menchón JM, Minuzzii L, Morer A, Nakamae T, Nakao T, Narayanaswamy JC, Nishida S, Nurmi E, O’neill J, Piacentini J, Piras F, Piras F, Reddy YJ, Reess TJ, Sakai Y, Sato JR, Simpson HB, Soreni N, Soriano-Mas C, Spalletta G, Stevens MC, Szeszko PR, Tolin DF, van Wingen GA, Venkatasubramanian G, Walitza S, Wang Z, Yun JY, Thompson PM, Stein DJ, van den Heuvel OA. Cortical Abnormalities Associated With Pediatric and Adult Obsessive-Compulsive Disorder: Findings From the ENIGMA Obsessive-Compulsive Disorder Working Group. Am J Psychiatry 2018; 175:453-462. [PMID: 29377733 PMCID: PMC7106947 DOI: 10.1176/appi.ajp.2017.17050485] [Citation(s) in RCA: 149] [Impact Index Per Article: 24.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
OBJECTIVE Brain imaging studies of structural abnormalities in OCD have yielded inconsistent results, partly because of limited statistical power, clinical heterogeneity, and methodological differences. The authors conducted meta- and mega-analyses comprising the largest study of cortical morphometry in OCD ever undertaken. METHOD T1-weighted MRI scans of 1,905 OCD patients and 1,760 healthy controls from 27 sites worldwide were processed locally using FreeSurfer to assess cortical thickness and surface area. Effect sizes for differences between patients and controls, and associations with clinical characteristics, were calculated using linear regression models controlling for age, sex, site, and intracranial volume. RESULTS In adult OCD patients versus controls, we found a significantly lower surface area for the transverse temporal cortex and a thinner inferior parietal cortex. Medicated adult OCD patients also showed thinner cortices throughout the brain. In pediatric OCD patients compared with controls, we found significantly thinner inferior and superior parietal cortices, but none of the regions analyzed showed significant differences in surface area. However, medicated pediatric OCD patients had lower surface area in frontal regions. Cohen's d effect sizes varied from -0.10 to -0.33. CONCLUSIONS The parietal cortex was consistently implicated in both adults and children with OCD. More widespread cortical thickness abnormalities were found in medicated adult OCD patients, and more pronounced surface area deficits (mainly in frontal regions) were found in medicated pediatric OCD patients. These cortical measures represent distinct morphological features and may be differentially affected during different stages of development and illness, and possibly moderated by disease profile and medication.
Collapse
Affiliation(s)
- Premika S.W. Boedhoe
- Department of Psychiatry, VU university medical center, Amsterdam, The Netherlands,Department of Anatomy & Neurosciences, VU university medical center, Amsterdam, The Netherlands,Amsterdam Neuroscience, Amsterdam, The Netherlands
| | - Lianne Schmaal
- Department of Psychiatry, VU university medical center, Amsterdam, The Netherlands,Amsterdam Neuroscience, Amsterdam, The Netherlands,Orygen, The National Centre of Excellence in Youth Mental Health, Melbourne, Australia,Centre for Youth Mental Health, The University of Melbourne, Melbourne, VIC, Australia
| | - Yoshinari Abe
- Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - Pino Alonso
- Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain,Centro de Investigación Biomèdica en Red de Salud Mental (CIBERSAM), Barcelona, Spain,Department of Clinical Sciences, University of Barcelona, Spain
| | - Stephanie H. Ameis
- The Margaret and Wallace McCain Centre for Child, Youth & Family Mental Health, Campbell Family Mental Health Research Institute, The Centre for Addiction and Mental Health, Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Canada,Centre for Brain and Mental Health, The Hospital for Sick Children, Toronto, Canada
| | - Alan Anticevic
- Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, U.S.A
| | - Paul D. Arnold
- Mathison Centre for Mental Health Research & Education, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada,Department of Psychiatry, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
| | - Marcelo C. Batistuzzo
- Department of Psychiatry, Institute of Psychiatry, University of São Paulo School of Medicine, São Paulo, Brazil
| | - Francesco Benedetti
- Psychiatry and Clinical Psychobiology, Division of Neuroscience, Scientific Institute Ospedale San Raffaele, Milano, Italy
| | - Jan C. Beucke
- Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany
| | - Irene Bollettini
- Psychiatry and Clinical Psychobiology, Division of Neuroscience, Scientific Institute Ospedale San Raffaele, Milano, Italy
| | - Anushree Bose
- Obsessive-Compulsive Disorder (OCD) Clinic Department of Psychiatry National Institute of Mental Health & Neurosciences, Bangalore, India
| | - Silvia Brem
- Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric Hospital, University of Zurich, Zurich, Switzerland
| | - Anna Calvo
- Magnetic Resonance Image Core Facility, IDIBAPS (Institut d’Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain
| | - Rosa Calvo
- Centro de Investigación Biomèdica en Red de Salud Mental (CIBERSAM), Barcelona, Spain,Department of Child and Adolescent Psychiatry and Psychology, Institute of Neurosciences, Hospital Clínic Universitari, Barcelona, Spain
| | - Yuqi Cheng
- Department of Psychiatry, First Affiliated Hospital of Kunming Medical University, Kunming, China
| | - Kang Ik K. Cho
- Institute of Human Behavioral Medicine, SNU-MRC, Seoul, Republic of Korea
| | - Valentina Ciullo
- Laboratory of Neuropsychiatry, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy
| | - Sara Dallaspezia
- Psychiatry and Clinical Psychobiology, Division of Neuroscience, Scientific Institute Ospedale San Raffaele, Milano, Italy
| | - Damiaan Denys
- Amsterdam Neuroscience, Amsterdam, The Netherlands,Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands,Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences, Amsterdam, The Netherlands
| | - Jamie D. Feusner
- Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA, U.S.A
| | - Kate D. Fitzgerald
- Department of Psychiatry, University of Michigan, Ann Arbor, Michigan, U.S.A
| | - Jean-Paul Fouche
- Department of Psychiatry, University of Cape Town, Cape Town, South Africa
| | - Egill A. Fridgeirsson
- Amsterdam Neuroscience, Amsterdam, The Netherlands,Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
| | - Patricia Gruner
- Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, U.S.A
| | - Gregory L. Hanna
- Department of Psychiatry, University of Michigan, Ann Arbor, Michigan, U.S.A
| | - Derrek P. Hibar
- Imaging Genetics Center, Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of the University of Southern California, Marina del Rey, CA, U.S.A
| | - Marcelo Q. Hoexter
- Department of Psychiatry, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
| | - Hao Hu
- Shanghai Mental Health Center Shanghai Jiao Tong University School of Medicine, PR China
| | - Chaim Huyser
- De Bascule, Academic Center for Child and Adolescent Psychiatry, Amsterdam, the Netherlands,Department of Child and Adolescent Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
| | - Neda Jahanshad
- Imaging Genetics Center, Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of the University of Southern California, Marina del Rey, CA, U.S.A
| | - Anthony James
- Department of Psychiatry, Oxford University, Oxford, U.K
| | - Norbert Kathmann
- Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany
| | - Christian Kaufmann
- Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany
| | - Kathrin Koch
- Department of Neuroradiology, Klinikum rechts der Isar, Technische Universität München, Germany,TUM-Neuroimaging Center (TUM-NIC) of Klinikum rechts der Isar, Technische Universität München, Germany
| | - Jun Soo Kwon
- Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea,Department of Brain & Cognitive Sciences, Seoul National University College of Natural Sciences, Seoul, Republic of Korea
| | - Luisa Lazaro
- Centro de Investigación Biomèdica en Red de Salud Mental (CIBERSAM), Barcelona, Spain,Department of Child and Adolescent Psychiatry and Psychology, Institute of Neurosciences, Hospital Clínic Universitari, Barcelona, Spain,Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain,Department of Medicine, University of Barcelona, Barcelona, Spain
| | - Christine Lochner
- SU/UCT MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, South Africa
| | - Rachel Marsh
- Columbia University Medical College, Columbia University, New York, NY, U.S.A.,The New York State Psychiatric Institute, New York, NY, U.S.A
| | - Ignacio Martínez-Zalacaín
- Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain
| | - David Mataix-Cols
- Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, Stockholm, Sweden
| | - José M. Menchón
- Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain,Centro de Investigación Biomèdica en Red de Salud Mental (CIBERSAM), Barcelona, Spain,Department of Clinical Sciences, University of Barcelona, Spain
| | - Luciano Minuzzii
- Mood Disorders Clinic, St. Joseph’s HealthCare, Hamilton, Ontario, Canada
| | - Astrid Morer
- Centro de Investigación Biomèdica en Red de Salud Mental (CIBERSAM), Barcelona, Spain,Department of Child and Adolescent Psychiatry and Psychology, Institute of Neurosciences, Hospital Clínic Universitari, Barcelona, Spain,Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
| | - Takashi Nakamae
- Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - Tomohiro Nakao
- Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
| | - Janardhanan C. Narayanaswamy
- Obsessive-Compulsive Disorder (OCD) Clinic Department of Psychiatry National Institute of Mental Health & Neurosciences, Bangalore, India
| | - Seiji Nishida
- Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - Erika Nurmi
- Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA, U.S.A
| | - Joseph O’neill
- Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA, U.S.A
| | - John Piacentini
- Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA, U.S.A
| | - Fabrizio Piras
- Laboratory of Neuropsychiatry, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy,Centro Fermi - Museo Storico della Fisica e Centro Studi e Ricerche “Enrico Fermi”
| | - Federica Piras
- Laboratory of Neuropsychiatry, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy
| | - Y.C. Janardhan Reddy
- Obsessive-Compulsive Disorder (OCD) Clinic Department of Psychiatry National Institute of Mental Health & Neurosciences, Bangalore, India
| | - Tim J. Reess
- Department of Neuroradiology, Klinikum rechts der Isar, Technische Universität München, Germany,TUM-Neuroimaging Center (TUM-NIC) of Klinikum rechts der Isar, Technische Universität München, Germany
| | - Yuki Sakai
- Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan,ATR Brain Information Communication Research Laboratory Group, Kyoto, Japan
| | - Joao R. Sato
- Center for Mathematics, Computing and Cognition, Universidade Federal do ABC, Santo Andre, Brazil
| | - H. Blair Simpson
- Columbia University Medical College, Columbia University, New York, NY, U.S.A.,Center for OCD and Related Disorders, New York State Psychiatric Institute, New York, NY, U.S.A
| | - Noam Soreni
- Anxiety Treatment and Research Center, St. Joseph’s HealthCare, Hamilton, Ontario, Canada
| | - Carles Soriano-Mas
- Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain,Centro de Investigación Biomèdica en Red de Salud Mental (CIBERSAM), Barcelona, Spain,Department of Psychobiology and Methodology of Health Sciences, Universitat Autònoma de Barcelona, Spain
| | - Gianfranco Spalletta
- Laboratory of Neuropsychiatry, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy,Beth K. and Stuart C. Yudofsky Division of Neuropsychiatry, Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, Texas, USA
| | - Michael C. Stevens
- Yale University School of Medicine, New Haven, Connecticut, U.S.A.,Clinical Neuroscience and Development Laboratory, Olin Neuropsychiatry Research Center, Hartford, Connecticut, U.S.A
| | - Philip R. Szeszko
- Icahn School of Medicine at Mount Sinai, New York, U.S.A.,James J. Peters VA Medical Center, Bronx, New York, U.S.A
| | - David F. Tolin
- Yale University School of Medicine, New Haven, Connecticut, U.S.A.,Institute of Living/Hartford Hospital, Hartford, Connecticut, U.S.A
| | - Guido A. van Wingen
- Amsterdam Neuroscience, Amsterdam, The Netherlands,Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
| | - Ganesan Venkatasubramanian
- Obsessive-Compulsive Disorder (OCD) Clinic Department of Psychiatry National Institute of Mental Health & Neurosciences, Bangalore, India
| | - Susanne Walitza
- Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric Hospital, University of Zurich, Zurich, Switzerland
| | - Zhen Wang
- Shanghai Mental Health Center Shanghai Jiao Tong University School of Medicine, PR China,Shanghai Key Laboratory of Psychotic Disorders, PR China
| | - Je-Yeon Yun
- Yeongeon Student Support Center, Seoul National University College of Medicine, Seoul, Republic of Korea,Seoul National University Hospital, Seoul, Republic of Korea
| | | | - Paul M. Thompson
- Imaging Genetics Center, Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of the University of Southern California, Marina del Rey, CA, U.S.A
| | - Dan J. Stein
- Department of Psychiatry, University of Cape Town, Cape Town, South Africa
| | - Odile A. van den Heuvel
- Department of Psychiatry, VU university medical center, Amsterdam, The Netherlands,Department of Anatomy & Neurosciences, VU university medical center, Amsterdam, The Netherlands,Amsterdam Neuroscience, Amsterdam, The Netherlands
| | | |
Collapse
|
10
|
Boedhoe PS, Schmaal L, Mataix-Cols D, Jahanshad N, Thompson PM, Stein D, van den Heuvel OA, Abe Y, Alonso P, Ameis SH, Arnold PD, Bargalló N, Batistuzzo MC, Benedetti F, Beucke JC, Boedhoe PS, Bollettini I, Bose A, Brem S, Busatto GF, Calvo A, Calvo R, Cath DC, Cheng Y, Cho KIK, Dallaspezia S, de Vries FE, de Wit SJ, Denys D, Fang Y, Fitzgerald KD, Fontaine M, Fouche JP, Giménez M, Gruner P, Hanna GL, Hibar DP, Hoexter MQ, Hu H, Huyser C, Ikari K, Jahanshad N, Kathmann N, Kaufmann C, Khadka S, Koch K, Kwon JS, Lazaro L, Liu Y, Lochner C, Marsh R, Martínez-Zalacaín I, Mataix-Cols D, Menchón JM, Miguel EC, Minuzzii L, Morer A, Nakamae T, Nakao T, Narayanaswamy JC, Piras F, Piras F, Pittenger C, Reddy YJ, Sato JR, Simpson HB, Schmaal L, Soreni N, Soriano-Mas C, Spalletta G, Stein DJ, Stevens MC, Szeszko PR, Thompson PM, Tolin DF, Veltman DJ, Venkatasubramanian G, van den Heuvel OA, van der Werf YD, van Wingen GA, Walitza S, Wang Z, Xu J, Xu X, Yun JY, Zhao Q. Association and Causation in Brain Imaging in the Case of OCD: Response to McKay et al. Am J Psychiatry 2017; 174:597-599. [PMID: 28565945 PMCID: PMC6546159 DOI: 10.1176/appi.ajp.2017.17010019r] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Affiliation(s)
- Premika S.W. Boedhoe
- From the Departments of Psychiatry and of Anatomy and Neurosciences, VU University Medical Center, Amsterdam; Amsterdam Neuroscience, Amsterdam; Orygen, The National Centre of Excellence in Youth Mental Health, Melbourne; the Department of Clinical Neuroscience, Centre for Psychiatric Research and Education, Karolinska Institutet, Stockholm; the Imaging Genetics Center, Keck School of Medicine, USC, Marina del Rey, Calif.; and SU/UCT Medical Research Council Unit on Anxiety and Stress Disorders,
| | - Lianne Schmaal
- From the Departments of Psychiatry and of Anatomy and Neurosciences, VU University Medical Center, Amsterdam; Amsterdam Neuroscience, Amsterdam; Orygen, The National Centre of Excellence in Youth Mental Health, Melbourne; the Department of Clinical Neuroscience, Centre for Psychiatric Research and Education, Karolinska Institutet, Stockholm; the Imaging Genetics Center, Keck School of Medicine, USC, Marina del Rey, Calif.; and SU/UCT Medical Research Council Unit on Anxiety and Stress Disorders,
| | - David Mataix-Cols
- From the Departments of Psychiatry and of Anatomy and Neurosciences, VU University Medical Center, Amsterdam; Amsterdam Neuroscience, Amsterdam; Orygen, The National Centre of Excellence in Youth Mental Health, Melbourne; the Department of Clinical Neuroscience, Centre for Psychiatric Research and Education, Karolinska Institutet, Stockholm; the Imaging Genetics Center, Keck School of Medicine, USC, Marina del Rey, Calif.; and SU/UCT Medical Research Council Unit on Anxiety and Stress Disorders,
| | - Neda Jahanshad
- From the Departments of Psychiatry and of Anatomy and Neurosciences, VU University Medical Center, Amsterdam; Amsterdam Neuroscience, Amsterdam; Orygen, The National Centre of Excellence in Youth Mental Health, Melbourne; the Department of Clinical Neuroscience, Centre for Psychiatric Research and Education, Karolinska Institutet, Stockholm; the Imaging Genetics Center, Keck School of Medicine, USC, Marina del Rey, Calif.; and SU/UCT Medical Research Council Unit on Anxiety and Stress Disorders,
| | - Paul M. Thompson
- From the Departments of Psychiatry and of Anatomy and Neurosciences, VU University Medical Center, Amsterdam; Amsterdam Neuroscience, Amsterdam; Orygen, The National Centre of Excellence in Youth Mental Health, Melbourne; the Department of Clinical Neuroscience, Centre for Psychiatric Research and Education, Karolinska Institutet, Stockholm; the Imaging Genetics Center, Keck School of Medicine, USC, Marina del Rey, Calif.; and SU/UCT Medical Research Council Unit on Anxiety and Stress Disorders,
| | - Dan Stein
- From the Departments of Psychiatry and of Anatomy and Neurosciences, VU University Medical Center, Amsterdam; Amsterdam Neuroscience, Amsterdam; Orygen, The National Centre of Excellence in Youth Mental Health, Melbourne; the Department of Clinical Neuroscience, Centre for Psychiatric Research and Education, Karolinska Institutet, Stockholm; the Imaging Genetics Center, Keck School of Medicine, USC, Marina del Rey, Calif.; and SU/UCT Medical Research Council Unit on Anxiety and Stress Disorders,
| | - Odile A. van den Heuvel
- From the Departments of Psychiatry and of Anatomy and Neurosciences, VU University Medical Center, Amsterdam; Amsterdam Neuroscience, Amsterdam; Orygen, The National Centre of Excellence in Youth Mental Health, Melbourne; the Department of Clinical Neuroscience, Centre for Psychiatric Research and Education, Karolinska Institutet, Stockholm; the Imaging Genetics Center, Keck School of Medicine, USC, Marina del Rey, Calif.; and SU/UCT Medical Research Council Unit on Anxiety and Stress Disorders,
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Fouche JP, du Plessis S, Hattingh C, Roos A, Lochner C, Soriano-Mas C, Sato JR, Nakamae T, Nishida S, Kwon JS, Jung WH, Mataix-Cols D, Hoexter MQ, Alonso P, de Wit SJ, Veltman DJ, Stein DJ, van den Heuvel OA. Cortical thickness in obsessive-compulsive disorder: multisite mega-analysis of 780 brain scans from six centres. Br J Psychiatry 2017; 210:67-74. [PMID: 27198485 DOI: 10.1192/bjp.bp.115.164020] [Citation(s) in RCA: 69] [Impact Index Per Article: 9.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/24/2015] [Revised: 08/18/2015] [Accepted: 09/27/2015] [Indexed: 01/24/2023]
Abstract
BACKGROUND There is accumulating evidence for the role of fronto-striatal and associated circuits in obsessive-compulsive disorder (OCD) but limited and conflicting data on alterations in cortical thickness. AIMS To investigate alterations in cortical thickness and subcortical volume in OCD. METHOD In total, 412 patients with OCD and 368 healthy adults underwent magnetic resonance imaging scans. Between-group analysis of covariance of cortical thickness and subcortical volumes was performed and regression analyses undertaken. RESULTS Significantly decreased cortical thickness was found in the OCD group compared with controls in the superior and inferior frontal, precentral, posterior cingulate, middle temporal, inferior parietal and precuneus gyri. There was also a group × age interaction in the parietal cortex, with increased thinning with age in the OCD group relative to controls. CONCLUSIONS Our findings are partially consistent with earlier work, suggesting that group differences in grey matter volume and cortical thickness could relate to the same underlying pathology of OCD. They partially support a frontostriatal model of OCD, but also suggest that limbic, temporal and parietal regions play a role in the pathophysiology of the disorder. The group × age interaction effects may be the result of altered neuroplasticity.
Collapse
Affiliation(s)
- Jean-Paul Fouche
- Jean-Paul Fouche, MSc, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Stefan du Plessis, MD, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Coenie Hattingh, MSc, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Annerine Roos, PhD, MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Christine Lochner, PhD, MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Carles Soriano-Mas, PhD, Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain, Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain, and Department of Psychobiology and Methodology in Health Sciences, Universitat Autònoma de Barcelona, Spain; Joao R. Sato, PhD, Center of Mathematics, Computation and Cognition, Universidade Federal do ABC, Santo Andre, Brazil and Laboratório Interdisciplinar de Neurociências Clínicas, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil; Takashi Nakamae, MD, PhD, Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Seiji Nishida, MD, PhD, Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Jun Soo Kwon, MD, PhD, Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea and Institute of Human Behavioral Medicine, SNU-MRC, Seoul, Republic of Korea and Department of Brain and Cognitive Sciences, College of Natural Sciences, Seoul National University, Seoul, Republic of Korea; Wi Hoon Jung, PhD, Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea; David Mataix-Cols, PhD, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden; Marcelo Q. Hoexter, MD, PhD, Laboratório Interdisciplinar de Neurociências Clínicas, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil and Department & Institute of Psychiatry, University of Sao Paulo Medical School, Sao Paulo, Brazil; Pino Alonso, MD, PhD, Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain and Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain, and Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Spain; Stella J. de Wit, MD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands; Dick J. Veltman, MD, PhD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands; Dan J. Stein, MD, PhD, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa and MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Odile A. van den Heuvel, MD, PhD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands, Department of Anatomy & Neurosciences, VU University Medical Center, Amsterdam, The Netherlands
| | - Stefan du Plessis
- Jean-Paul Fouche, MSc, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Stefan du Plessis, MD, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Coenie Hattingh, MSc, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Annerine Roos, PhD, MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Christine Lochner, PhD, MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Carles Soriano-Mas, PhD, Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain, Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain, and Department of Psychobiology and Methodology in Health Sciences, Universitat Autònoma de Barcelona, Spain; Joao R. Sato, PhD, Center of Mathematics, Computation and Cognition, Universidade Federal do ABC, Santo Andre, Brazil and Laboratório Interdisciplinar de Neurociências Clínicas, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil; Takashi Nakamae, MD, PhD, Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Seiji Nishida, MD, PhD, Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Jun Soo Kwon, MD, PhD, Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea and Institute of Human Behavioral Medicine, SNU-MRC, Seoul, Republic of Korea and Department of Brain and Cognitive Sciences, College of Natural Sciences, Seoul National University, Seoul, Republic of Korea; Wi Hoon Jung, PhD, Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea; David Mataix-Cols, PhD, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden; Marcelo Q. Hoexter, MD, PhD, Laboratório Interdisciplinar de Neurociências Clínicas, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil and Department & Institute of Psychiatry, University of Sao Paulo Medical School, Sao Paulo, Brazil; Pino Alonso, MD, PhD, Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain and Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain, and Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Spain; Stella J. de Wit, MD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands; Dick J. Veltman, MD, PhD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands; Dan J. Stein, MD, PhD, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa and MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Odile A. van den Heuvel, MD, PhD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands, Department of Anatomy & Neurosciences, VU University Medical Center, Amsterdam, The Netherlands
| | - Coenie Hattingh
- Jean-Paul Fouche, MSc, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Stefan du Plessis, MD, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Coenie Hattingh, MSc, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Annerine Roos, PhD, MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Christine Lochner, PhD, MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Carles Soriano-Mas, PhD, Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain, Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain, and Department of Psychobiology and Methodology in Health Sciences, Universitat Autònoma de Barcelona, Spain; Joao R. Sato, PhD, Center of Mathematics, Computation and Cognition, Universidade Federal do ABC, Santo Andre, Brazil and Laboratório Interdisciplinar de Neurociências Clínicas, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil; Takashi Nakamae, MD, PhD, Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Seiji Nishida, MD, PhD, Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Jun Soo Kwon, MD, PhD, Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea and Institute of Human Behavioral Medicine, SNU-MRC, Seoul, Republic of Korea and Department of Brain and Cognitive Sciences, College of Natural Sciences, Seoul National University, Seoul, Republic of Korea; Wi Hoon Jung, PhD, Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea; David Mataix-Cols, PhD, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden; Marcelo Q. Hoexter, MD, PhD, Laboratório Interdisciplinar de Neurociências Clínicas, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil and Department & Institute of Psychiatry, University of Sao Paulo Medical School, Sao Paulo, Brazil; Pino Alonso, MD, PhD, Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain and Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain, and Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Spain; Stella J. de Wit, MD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands; Dick J. Veltman, MD, PhD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands; Dan J. Stein, MD, PhD, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa and MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Odile A. van den Heuvel, MD, PhD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands, Department of Anatomy & Neurosciences, VU University Medical Center, Amsterdam, The Netherlands
| | - Annerine Roos
- Jean-Paul Fouche, MSc, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Stefan du Plessis, MD, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Coenie Hattingh, MSc, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Annerine Roos, PhD, MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Christine Lochner, PhD, MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Carles Soriano-Mas, PhD, Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain, Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain, and Department of Psychobiology and Methodology in Health Sciences, Universitat Autònoma de Barcelona, Spain; Joao R. Sato, PhD, Center of Mathematics, Computation and Cognition, Universidade Federal do ABC, Santo Andre, Brazil and Laboratório Interdisciplinar de Neurociências Clínicas, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil; Takashi Nakamae, MD, PhD, Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Seiji Nishida, MD, PhD, Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Jun Soo Kwon, MD, PhD, Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea and Institute of Human Behavioral Medicine, SNU-MRC, Seoul, Republic of Korea and Department of Brain and Cognitive Sciences, College of Natural Sciences, Seoul National University, Seoul, Republic of Korea; Wi Hoon Jung, PhD, Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea; David Mataix-Cols, PhD, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden; Marcelo Q. Hoexter, MD, PhD, Laboratório Interdisciplinar de Neurociências Clínicas, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil and Department & Institute of Psychiatry, University of Sao Paulo Medical School, Sao Paulo, Brazil; Pino Alonso, MD, PhD, Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain and Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain, and Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Spain; Stella J. de Wit, MD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands; Dick J. Veltman, MD, PhD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands; Dan J. Stein, MD, PhD, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa and MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Odile A. van den Heuvel, MD, PhD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands, Department of Anatomy & Neurosciences, VU University Medical Center, Amsterdam, The Netherlands
| | - Christine Lochner
- Jean-Paul Fouche, MSc, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Stefan du Plessis, MD, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Coenie Hattingh, MSc, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Annerine Roos, PhD, MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Christine Lochner, PhD, MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Carles Soriano-Mas, PhD, Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain, Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain, and Department of Psychobiology and Methodology in Health Sciences, Universitat Autònoma de Barcelona, Spain; Joao R. Sato, PhD, Center of Mathematics, Computation and Cognition, Universidade Federal do ABC, Santo Andre, Brazil and Laboratório Interdisciplinar de Neurociências Clínicas, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil; Takashi Nakamae, MD, PhD, Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Seiji Nishida, MD, PhD, Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Jun Soo Kwon, MD, PhD, Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea and Institute of Human Behavioral Medicine, SNU-MRC, Seoul, Republic of Korea and Department of Brain and Cognitive Sciences, College of Natural Sciences, Seoul National University, Seoul, Republic of Korea; Wi Hoon Jung, PhD, Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea; David Mataix-Cols, PhD, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden; Marcelo Q. Hoexter, MD, PhD, Laboratório Interdisciplinar de Neurociências Clínicas, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil and Department & Institute of Psychiatry, University of Sao Paulo Medical School, Sao Paulo, Brazil; Pino Alonso, MD, PhD, Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain and Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain, and Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Spain; Stella J. de Wit, MD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands; Dick J. Veltman, MD, PhD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands; Dan J. Stein, MD, PhD, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa and MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Odile A. van den Heuvel, MD, PhD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands, Department of Anatomy & Neurosciences, VU University Medical Center, Amsterdam, The Netherlands
| | - Carles Soriano-Mas
- Jean-Paul Fouche, MSc, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Stefan du Plessis, MD, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Coenie Hattingh, MSc, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Annerine Roos, PhD, MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Christine Lochner, PhD, MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Carles Soriano-Mas, PhD, Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain, Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain, and Department of Psychobiology and Methodology in Health Sciences, Universitat Autònoma de Barcelona, Spain; Joao R. Sato, PhD, Center of Mathematics, Computation and Cognition, Universidade Federal do ABC, Santo Andre, Brazil and Laboratório Interdisciplinar de Neurociências Clínicas, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil; Takashi Nakamae, MD, PhD, Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Seiji Nishida, MD, PhD, Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Jun Soo Kwon, MD, PhD, Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea and Institute of Human Behavioral Medicine, SNU-MRC, Seoul, Republic of Korea and Department of Brain and Cognitive Sciences, College of Natural Sciences, Seoul National University, Seoul, Republic of Korea; Wi Hoon Jung, PhD, Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea; David Mataix-Cols, PhD, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden; Marcelo Q. Hoexter, MD, PhD, Laboratório Interdisciplinar de Neurociências Clínicas, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil and Department & Institute of Psychiatry, University of Sao Paulo Medical School, Sao Paulo, Brazil; Pino Alonso, MD, PhD, Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain and Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain, and Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Spain; Stella J. de Wit, MD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands; Dick J. Veltman, MD, PhD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands; Dan J. Stein, MD, PhD, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa and MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Odile A. van den Heuvel, MD, PhD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands, Department of Anatomy & Neurosciences, VU University Medical Center, Amsterdam, The Netherlands
| | - Joao R Sato
- Jean-Paul Fouche, MSc, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Stefan du Plessis, MD, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Coenie Hattingh, MSc, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Annerine Roos, PhD, MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Christine Lochner, PhD, MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Carles Soriano-Mas, PhD, Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain, Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain, and Department of Psychobiology and Methodology in Health Sciences, Universitat Autònoma de Barcelona, Spain; Joao R. Sato, PhD, Center of Mathematics, Computation and Cognition, Universidade Federal do ABC, Santo Andre, Brazil and Laboratório Interdisciplinar de Neurociências Clínicas, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil; Takashi Nakamae, MD, PhD, Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Seiji Nishida, MD, PhD, Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Jun Soo Kwon, MD, PhD, Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea and Institute of Human Behavioral Medicine, SNU-MRC, Seoul, Republic of Korea and Department of Brain and Cognitive Sciences, College of Natural Sciences, Seoul National University, Seoul, Republic of Korea; Wi Hoon Jung, PhD, Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea; David Mataix-Cols, PhD, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden; Marcelo Q. Hoexter, MD, PhD, Laboratório Interdisciplinar de Neurociências Clínicas, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil and Department & Institute of Psychiatry, University of Sao Paulo Medical School, Sao Paulo, Brazil; Pino Alonso, MD, PhD, Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain and Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain, and Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Spain; Stella J. de Wit, MD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands; Dick J. Veltman, MD, PhD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands; Dan J. Stein, MD, PhD, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa and MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Odile A. van den Heuvel, MD, PhD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands, Department of Anatomy & Neurosciences, VU University Medical Center, Amsterdam, The Netherlands
| | - Takashi Nakamae
- Jean-Paul Fouche, MSc, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Stefan du Plessis, MD, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Coenie Hattingh, MSc, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Annerine Roos, PhD, MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Christine Lochner, PhD, MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Carles Soriano-Mas, PhD, Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain, Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain, and Department of Psychobiology and Methodology in Health Sciences, Universitat Autònoma de Barcelona, Spain; Joao R. Sato, PhD, Center of Mathematics, Computation and Cognition, Universidade Federal do ABC, Santo Andre, Brazil and Laboratório Interdisciplinar de Neurociências Clínicas, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil; Takashi Nakamae, MD, PhD, Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Seiji Nishida, MD, PhD, Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Jun Soo Kwon, MD, PhD, Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea and Institute of Human Behavioral Medicine, SNU-MRC, Seoul, Republic of Korea and Department of Brain and Cognitive Sciences, College of Natural Sciences, Seoul National University, Seoul, Republic of Korea; Wi Hoon Jung, PhD, Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea; David Mataix-Cols, PhD, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden; Marcelo Q. Hoexter, MD, PhD, Laboratório Interdisciplinar de Neurociências Clínicas, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil and Department & Institute of Psychiatry, University of Sao Paulo Medical School, Sao Paulo, Brazil; Pino Alonso, MD, PhD, Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain and Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain, and Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Spain; Stella J. de Wit, MD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands; Dick J. Veltman, MD, PhD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands; Dan J. Stein, MD, PhD, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa and MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Odile A. van den Heuvel, MD, PhD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands, Department of Anatomy & Neurosciences, VU University Medical Center, Amsterdam, The Netherlands
| | - Seiji Nishida
- Jean-Paul Fouche, MSc, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Stefan du Plessis, MD, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Coenie Hattingh, MSc, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Annerine Roos, PhD, MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Christine Lochner, PhD, MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Carles Soriano-Mas, PhD, Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain, Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain, and Department of Psychobiology and Methodology in Health Sciences, Universitat Autònoma de Barcelona, Spain; Joao R. Sato, PhD, Center of Mathematics, Computation and Cognition, Universidade Federal do ABC, Santo Andre, Brazil and Laboratório Interdisciplinar de Neurociências Clínicas, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil; Takashi Nakamae, MD, PhD, Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Seiji Nishida, MD, PhD, Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Jun Soo Kwon, MD, PhD, Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea and Institute of Human Behavioral Medicine, SNU-MRC, Seoul, Republic of Korea and Department of Brain and Cognitive Sciences, College of Natural Sciences, Seoul National University, Seoul, Republic of Korea; Wi Hoon Jung, PhD, Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea; David Mataix-Cols, PhD, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden; Marcelo Q. Hoexter, MD, PhD, Laboratório Interdisciplinar de Neurociências Clínicas, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil and Department & Institute of Psychiatry, University of Sao Paulo Medical School, Sao Paulo, Brazil; Pino Alonso, MD, PhD, Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain and Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain, and Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Spain; Stella J. de Wit, MD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands; Dick J. Veltman, MD, PhD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands; Dan J. Stein, MD, PhD, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa and MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Odile A. van den Heuvel, MD, PhD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands, Department of Anatomy & Neurosciences, VU University Medical Center, Amsterdam, The Netherlands
| | - Jun Soo Kwon
- Jean-Paul Fouche, MSc, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Stefan du Plessis, MD, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Coenie Hattingh, MSc, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Annerine Roos, PhD, MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Christine Lochner, PhD, MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Carles Soriano-Mas, PhD, Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain, Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain, and Department of Psychobiology and Methodology in Health Sciences, Universitat Autònoma de Barcelona, Spain; Joao R. Sato, PhD, Center of Mathematics, Computation and Cognition, Universidade Federal do ABC, Santo Andre, Brazil and Laboratório Interdisciplinar de Neurociências Clínicas, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil; Takashi Nakamae, MD, PhD, Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Seiji Nishida, MD, PhD, Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Jun Soo Kwon, MD, PhD, Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea and Institute of Human Behavioral Medicine, SNU-MRC, Seoul, Republic of Korea and Department of Brain and Cognitive Sciences, College of Natural Sciences, Seoul National University, Seoul, Republic of Korea; Wi Hoon Jung, PhD, Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea; David Mataix-Cols, PhD, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden; Marcelo Q. Hoexter, MD, PhD, Laboratório Interdisciplinar de Neurociências Clínicas, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil and Department & Institute of Psychiatry, University of Sao Paulo Medical School, Sao Paulo, Brazil; Pino Alonso, MD, PhD, Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain and Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain, and Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Spain; Stella J. de Wit, MD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands; Dick J. Veltman, MD, PhD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands; Dan J. Stein, MD, PhD, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa and MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Odile A. van den Heuvel, MD, PhD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands, Department of Anatomy & Neurosciences, VU University Medical Center, Amsterdam, The Netherlands
| | - Wi Hoon Jung
- Jean-Paul Fouche, MSc, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Stefan du Plessis, MD, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Coenie Hattingh, MSc, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Annerine Roos, PhD, MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Christine Lochner, PhD, MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Carles Soriano-Mas, PhD, Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain, Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain, and Department of Psychobiology and Methodology in Health Sciences, Universitat Autònoma de Barcelona, Spain; Joao R. Sato, PhD, Center of Mathematics, Computation and Cognition, Universidade Federal do ABC, Santo Andre, Brazil and Laboratório Interdisciplinar de Neurociências Clínicas, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil; Takashi Nakamae, MD, PhD, Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Seiji Nishida, MD, PhD, Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Jun Soo Kwon, MD, PhD, Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea and Institute of Human Behavioral Medicine, SNU-MRC, Seoul, Republic of Korea and Department of Brain and Cognitive Sciences, College of Natural Sciences, Seoul National University, Seoul, Republic of Korea; Wi Hoon Jung, PhD, Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea; David Mataix-Cols, PhD, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden; Marcelo Q. Hoexter, MD, PhD, Laboratório Interdisciplinar de Neurociências Clínicas, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil and Department & Institute of Psychiatry, University of Sao Paulo Medical School, Sao Paulo, Brazil; Pino Alonso, MD, PhD, Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain and Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain, and Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Spain; Stella J. de Wit, MD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands; Dick J. Veltman, MD, PhD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands; Dan J. Stein, MD, PhD, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa and MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Odile A. van den Heuvel, MD, PhD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands, Department of Anatomy & Neurosciences, VU University Medical Center, Amsterdam, The Netherlands
| | - David Mataix-Cols
- Jean-Paul Fouche, MSc, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Stefan du Plessis, MD, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Coenie Hattingh, MSc, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Annerine Roos, PhD, MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Christine Lochner, PhD, MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Carles Soriano-Mas, PhD, Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain, Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain, and Department of Psychobiology and Methodology in Health Sciences, Universitat Autònoma de Barcelona, Spain; Joao R. Sato, PhD, Center of Mathematics, Computation and Cognition, Universidade Federal do ABC, Santo Andre, Brazil and Laboratório Interdisciplinar de Neurociências Clínicas, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil; Takashi Nakamae, MD, PhD, Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Seiji Nishida, MD, PhD, Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Jun Soo Kwon, MD, PhD, Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea and Institute of Human Behavioral Medicine, SNU-MRC, Seoul, Republic of Korea and Department of Brain and Cognitive Sciences, College of Natural Sciences, Seoul National University, Seoul, Republic of Korea; Wi Hoon Jung, PhD, Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea; David Mataix-Cols, PhD, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden; Marcelo Q. Hoexter, MD, PhD, Laboratório Interdisciplinar de Neurociências Clínicas, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil and Department & Institute of Psychiatry, University of Sao Paulo Medical School, Sao Paulo, Brazil; Pino Alonso, MD, PhD, Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain and Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain, and Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Spain; Stella J. de Wit, MD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands; Dick J. Veltman, MD, PhD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands; Dan J. Stein, MD, PhD, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa and MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Odile A. van den Heuvel, MD, PhD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands, Department of Anatomy & Neurosciences, VU University Medical Center, Amsterdam, The Netherlands
| | - Marcelo Q Hoexter
- Jean-Paul Fouche, MSc, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Stefan du Plessis, MD, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Coenie Hattingh, MSc, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Annerine Roos, PhD, MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Christine Lochner, PhD, MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Carles Soriano-Mas, PhD, Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain, Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain, and Department of Psychobiology and Methodology in Health Sciences, Universitat Autònoma de Barcelona, Spain; Joao R. Sato, PhD, Center of Mathematics, Computation and Cognition, Universidade Federal do ABC, Santo Andre, Brazil and Laboratório Interdisciplinar de Neurociências Clínicas, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil; Takashi Nakamae, MD, PhD, Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Seiji Nishida, MD, PhD, Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Jun Soo Kwon, MD, PhD, Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea and Institute of Human Behavioral Medicine, SNU-MRC, Seoul, Republic of Korea and Department of Brain and Cognitive Sciences, College of Natural Sciences, Seoul National University, Seoul, Republic of Korea; Wi Hoon Jung, PhD, Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea; David Mataix-Cols, PhD, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden; Marcelo Q. Hoexter, MD, PhD, Laboratório Interdisciplinar de Neurociências Clínicas, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil and Department & Institute of Psychiatry, University of Sao Paulo Medical School, Sao Paulo, Brazil; Pino Alonso, MD, PhD, Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain and Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain, and Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Spain; Stella J. de Wit, MD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands; Dick J. Veltman, MD, PhD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands; Dan J. Stein, MD, PhD, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa and MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Odile A. van den Heuvel, MD, PhD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands, Department of Anatomy & Neurosciences, VU University Medical Center, Amsterdam, The Netherlands
| | - Pino Alonso
- Jean-Paul Fouche, MSc, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Stefan du Plessis, MD, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Coenie Hattingh, MSc, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Annerine Roos, PhD, MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Christine Lochner, PhD, MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Carles Soriano-Mas, PhD, Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain, Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain, and Department of Psychobiology and Methodology in Health Sciences, Universitat Autònoma de Barcelona, Spain; Joao R. Sato, PhD, Center of Mathematics, Computation and Cognition, Universidade Federal do ABC, Santo Andre, Brazil and Laboratório Interdisciplinar de Neurociências Clínicas, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil; Takashi Nakamae, MD, PhD, Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Seiji Nishida, MD, PhD, Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Jun Soo Kwon, MD, PhD, Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea and Institute of Human Behavioral Medicine, SNU-MRC, Seoul, Republic of Korea and Department of Brain and Cognitive Sciences, College of Natural Sciences, Seoul National University, Seoul, Republic of Korea; Wi Hoon Jung, PhD, Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea; David Mataix-Cols, PhD, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden; Marcelo Q. Hoexter, MD, PhD, Laboratório Interdisciplinar de Neurociências Clínicas, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil and Department & Institute of Psychiatry, University of Sao Paulo Medical School, Sao Paulo, Brazil; Pino Alonso, MD, PhD, Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain and Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain, and Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Spain; Stella J. de Wit, MD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands; Dick J. Veltman, MD, PhD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands; Dan J. Stein, MD, PhD, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa and MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Odile A. van den Heuvel, MD, PhD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands, Department of Anatomy & Neurosciences, VU University Medical Center, Amsterdam, The Netherlands
| | | | - Stella J de Wit
- Jean-Paul Fouche, MSc, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Stefan du Plessis, MD, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Coenie Hattingh, MSc, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Annerine Roos, PhD, MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Christine Lochner, PhD, MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Carles Soriano-Mas, PhD, Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain, Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain, and Department of Psychobiology and Methodology in Health Sciences, Universitat Autònoma de Barcelona, Spain; Joao R. Sato, PhD, Center of Mathematics, Computation and Cognition, Universidade Federal do ABC, Santo Andre, Brazil and Laboratório Interdisciplinar de Neurociências Clínicas, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil; Takashi Nakamae, MD, PhD, Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Seiji Nishida, MD, PhD, Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Jun Soo Kwon, MD, PhD, Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea and Institute of Human Behavioral Medicine, SNU-MRC, Seoul, Republic of Korea and Department of Brain and Cognitive Sciences, College of Natural Sciences, Seoul National University, Seoul, Republic of Korea; Wi Hoon Jung, PhD, Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea; David Mataix-Cols, PhD, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden; Marcelo Q. Hoexter, MD, PhD, Laboratório Interdisciplinar de Neurociências Clínicas, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil and Department & Institute of Psychiatry, University of Sao Paulo Medical School, Sao Paulo, Brazil; Pino Alonso, MD, PhD, Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain and Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain, and Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Spain; Stella J. de Wit, MD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands; Dick J. Veltman, MD, PhD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands; Dan J. Stein, MD, PhD, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa and MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Odile A. van den Heuvel, MD, PhD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands, Department of Anatomy & Neurosciences, VU University Medical Center, Amsterdam, The Netherlands
| | - Dick J Veltman
- Jean-Paul Fouche, MSc, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Stefan du Plessis, MD, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Coenie Hattingh, MSc, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Annerine Roos, PhD, MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Christine Lochner, PhD, MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Carles Soriano-Mas, PhD, Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain, Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain, and Department of Psychobiology and Methodology in Health Sciences, Universitat Autònoma de Barcelona, Spain; Joao R. Sato, PhD, Center of Mathematics, Computation and Cognition, Universidade Federal do ABC, Santo Andre, Brazil and Laboratório Interdisciplinar de Neurociências Clínicas, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil; Takashi Nakamae, MD, PhD, Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Seiji Nishida, MD, PhD, Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Jun Soo Kwon, MD, PhD, Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea and Institute of Human Behavioral Medicine, SNU-MRC, Seoul, Republic of Korea and Department of Brain and Cognitive Sciences, College of Natural Sciences, Seoul National University, Seoul, Republic of Korea; Wi Hoon Jung, PhD, Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea; David Mataix-Cols, PhD, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden; Marcelo Q. Hoexter, MD, PhD, Laboratório Interdisciplinar de Neurociências Clínicas, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil and Department & Institute of Psychiatry, University of Sao Paulo Medical School, Sao Paulo, Brazil; Pino Alonso, MD, PhD, Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain and Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain, and Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Spain; Stella J. de Wit, MD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands; Dick J. Veltman, MD, PhD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands; Dan J. Stein, MD, PhD, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa and MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Odile A. van den Heuvel, MD, PhD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands, Department of Anatomy & Neurosciences, VU University Medical Center, Amsterdam, The Netherlands
| | - Dan J Stein
- Jean-Paul Fouche, MSc, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Stefan du Plessis, MD, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Coenie Hattingh, MSc, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Annerine Roos, PhD, MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Christine Lochner, PhD, MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Carles Soriano-Mas, PhD, Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain, Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain, and Department of Psychobiology and Methodology in Health Sciences, Universitat Autònoma de Barcelona, Spain; Joao R. Sato, PhD, Center of Mathematics, Computation and Cognition, Universidade Federal do ABC, Santo Andre, Brazil and Laboratório Interdisciplinar de Neurociências Clínicas, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil; Takashi Nakamae, MD, PhD, Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Seiji Nishida, MD, PhD, Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Jun Soo Kwon, MD, PhD, Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea and Institute of Human Behavioral Medicine, SNU-MRC, Seoul, Republic of Korea and Department of Brain and Cognitive Sciences, College of Natural Sciences, Seoul National University, Seoul, Republic of Korea; Wi Hoon Jung, PhD, Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea; David Mataix-Cols, PhD, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden; Marcelo Q. Hoexter, MD, PhD, Laboratório Interdisciplinar de Neurociências Clínicas, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil and Department & Institute of Psychiatry, University of Sao Paulo Medical School, Sao Paulo, Brazil; Pino Alonso, MD, PhD, Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain and Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain, and Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Spain; Stella J. de Wit, MD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands; Dick J. Veltman, MD, PhD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands; Dan J. Stein, MD, PhD, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa and MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Odile A. van den Heuvel, MD, PhD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands, Department of Anatomy & Neurosciences, VU University Medical Center, Amsterdam, The Netherlands
| | - Odile A van den Heuvel
- Jean-Paul Fouche, MSc, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Stefan du Plessis, MD, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Coenie Hattingh, MSc, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Annerine Roos, PhD, MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Christine Lochner, PhD, MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Carles Soriano-Mas, PhD, Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain, Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain, and Department of Psychobiology and Methodology in Health Sciences, Universitat Autònoma de Barcelona, Spain; Joao R. Sato, PhD, Center of Mathematics, Computation and Cognition, Universidade Federal do ABC, Santo Andre, Brazil and Laboratório Interdisciplinar de Neurociências Clínicas, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil; Takashi Nakamae, MD, PhD, Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Seiji Nishida, MD, PhD, Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Jun Soo Kwon, MD, PhD, Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea and Institute of Human Behavioral Medicine, SNU-MRC, Seoul, Republic of Korea and Department of Brain and Cognitive Sciences, College of Natural Sciences, Seoul National University, Seoul, Republic of Korea; Wi Hoon Jung, PhD, Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea; David Mataix-Cols, PhD, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden; Marcelo Q. Hoexter, MD, PhD, Laboratório Interdisciplinar de Neurociências Clínicas, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil and Department & Institute of Psychiatry, University of Sao Paulo Medical School, Sao Paulo, Brazil; Pino Alonso, MD, PhD, Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain and Carlos III Health Institute, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain, and Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Spain; Stella J. de Wit, MD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands; Dick J. Veltman, MD, PhD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands; Dan J. Stein, MD, PhD, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa and MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Odile A. van den Heuvel, MD, PhD, Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands, Department of Anatomy & Neurosciences, VU University Medical Center, Amsterdam, The Netherlands
| |
Collapse
|
12
|
Boedhoe PS, Schmaal L, Abe Y, Ameis SH, Arnold PD, Batistuzzo MC, Benedetti F, Beucke JC, Bollettini I, Bose A, Brem S, Calvo A, Cheng Y, Cho KIK, Dallaspezia S, Denys D, Fitzgerald KD, Fouche JP, Giménez M, Gruner P, Hanna GL, Hibar DP, Hoexter MQ, Huyser C, Ikari K, Jahanshad N, Kathmann N, Kaufmann C, Koch K, Kwon JS, Lazaro L, Liu Y, Lochner C, Marsh R, Martínez-Zalacaín I, Mataix-Cols D, Menchón JM, Minuzzii L, Nakamae T, Nakao T, Narayanaswamy JC, Piras F, Piras F, Pittenger C, Reddy YJ, Sato JR, Simpson HB, Soreni N, Soriano-Mas C, Spalletta G, Stevens MC, Szeszko PR, Tolin DF, Venkatasubramanian G, Walitza S, Wang Z, van Wingen GA, Xu J, Xu X, Yun JY, Zhao Q, Thompson PM, Stein DJ, van den Heuvel OA, van den Heuvel OA. Distinct Subcortical Volume Alterations in Pediatric and Adult OCD: A Worldwide Meta- and Mega-Analysis. Am J Psychiatry 2017; 174:60-69. [PMID: 27609241 PMCID: PMC5344782 DOI: 10.1176/appi.ajp.2016.16020201] [Citation(s) in RCA: 210] [Impact Index Per Article: 30.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
OBJECTIVE Structural brain imaging studies in obsessive-compulsive disorder (OCD) have produced inconsistent findings. This may be partially due to limited statistical power from relatively small samples and clinical heterogeneity related to variation in illness profile and developmental stage. To address these limitations, the authors conducted meta- and mega-analyses of data from OCD sites worldwide. METHOD T1 images from 1,830 OCD patients and 1,759 control subjects were analyzed, using coordinated and standardized processing, to identify subcortical brain volumes that differ between OCD patients and healthy subjects. The authors performed a meta-analysis on the mean of the left and right hemisphere measures of each subcortical structure, and they performed a mega-analysis by pooling these volumetric measurements from each site. The authors additionally examined potential modulating effects of clinical characteristics on morphological differences in OCD patients. RESULTS The meta-analysis indicated that adult patients had significantly smaller hippocampal volumes (Cohen's d=-0.13; % difference=-2.80) and larger pallidum volumes (d=0.16; % difference=3.16) compared with adult controls. Both effects were stronger in medicated patients compared with controls (d=-0.29, % difference=-4.18, and d=0.29, % difference=4.38, respectively). Unmedicated pediatric patients had significantly larger thalamic volumes (d=0.38, % difference=3.08) compared with pediatric controls. None of these findings were mediated by sample characteristics, such as mean age or scanning field strength. The mega-analysis yielded similar results. CONCLUSIONS The results indicate different patterns of subcortical abnormalities in pediatric and adult OCD patients. The pallidum and hippocampus seem to be of importance in adult OCD, whereas the thalamus seems to be key in pediatric OCD. These findings highlight the potential importance of neurodevelopmental alterations in OCD and suggest that further research on neuroplasticity in OCD may be useful.
Collapse
Affiliation(s)
- Premika S.W. Boedhoe
- Department of Psychiatry, VU university medical center, Amsterdam, The Netherlands,Department of Anatomy & Neurosciences, VU university medical center, Amsterdam, The Netherlands,Neuroscience Campus Amsterdam, Free University/VU university medical center, Amsterdam, The Netherlands
| | - Lianne Schmaal
- Department of Psychiatry, VU university medical center, Amsterdam, The Netherlands,Neuroscience Campus Amsterdam, Free University/VU university medical center, Amsterdam, The Netherlands
| | - Yoshinari Abe
- Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - Stephanie H. Ameis
- Centre for Addiction and Mental Health and Hospital for Sick Children, Toronto, Ontario, Canada
| | - Paul D. Arnold
- Mathison Centre for Mental Health Research & Education, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
| | - Marcelo C. Batistuzzo
- Department of Psychiatry, Institute of Psychiatry, University of São Paulo School of Medicine, São Paulo, Brazil
| | - Francesco Benedetti
- Clinical Research Group Psychiatry and Clinical Psychobiology, Division of Neuroscience, Scientific Institute Ospedale San Raffaele, Milano, Italy
| | - Jan C. Beucke
- Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany
| | - Irene Bollettini
- Clinical Research Group Psychiatry and Clinical Psychobiology, Division of Neuroscience, Scientific Institute Ospedale San Raffaele, Milano, Italy
| | - Anushree Bose
- Obsessive-Compulsive Disorder (OCD) Clinic, Department of Psychiatry National Institute of Mental Health & Neurosciences, Bangalore, India
| | - Silvia Brem
- Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric Hospital, University of Zurich, Zurich, Switzerland
| | - Anna Calvo
- Magnetic Resonance Image Core Facility, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
| | - Yuqi Cheng
- Department of Psychiatry, First Affiliated Hospital of Kunming Medical University, Kunming, China
| | - Kang Ik K. Cho
- Department of Brain & Cognitive Sciences, Seoul National University College of Natural Sciences, Seoul, Korea
| | - Sara Dallaspezia
- Clinical Research Group Psychiatry and Clinical Psychobiology, Division of Neuroscience, Scientific Institute Ospedale San Raffaele, Milano, Italy
| | - Damiaan Denys
- Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands,Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences, Amsterdam, The Netherlands
| | - Kate D. Fitzgerald
- Department of Psychiatry, University of Michigan, Ann Arbor, Michigan, U.S.A
| | - Jean-Paul Fouche
- Department of Psychiatry, University of Cape Town, Cape Town, South Africa,Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa
| | - Mònica Giménez
- Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain,entro de Investigación Biomèdica en Red de Salud Mental (CIBERSAM), Barcelona, Spain
| | - Patricia Gruner
- Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, U.S.A
| | - Gregory L. Hanna
- Department of Psychiatry, University of Michigan, Ann Arbor, Michigan, U.S.A
| | - Derrek P. Hibar
- Imaging Genetics Center, Mark and Mary Stevens Institute for Neuroimaging & Informatics, Keck School of Medicine of the University of Southern California, Marina del Rey, California, U.S.A
| | - Marcelo Q. Hoexter
- Department of Psychiatry, Institute of Psychiatry, University of São Paulo School of Medicine, São Paulo, Brazil
| | - Chaim Huyser
- De Bascule, Academic Center for Child and Adolescent Psychiatry, Amsterdam, The Netherlands,Department of Child and Adolescent Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
| | - Keisuke Ikari
- Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
| | - Neda Jahanshad
- Imaging Genetics Center, Mark and Mary Stevens Institute for Neuroimaging & Informatics, Keck School of Medicine of the University of Southern California, Marina del Rey, California, U.S.A
| | - Norbert Kathmann
- Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany
| | - Christian Kaufmann
- Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany
| | - Kathrin Koch
- Department of Neuroradiology, Klinikum rechts der Isar, Technische Universität München, München, Germany,TUM-Neuroimaging Center (TUM-NIC) of Klinikum rechts der Isar, Technische Universität München, München, Germany
| | - Jun Soo Kwon
- Department of Brain & Cognitive Sciences, Seoul National University College of Natural Sciences, Seoul, Korea,Department of Psychiatry, Seoul National University College of Medicine, Seoul, Korea
| | - Luisa Lazaro
- entro de Investigación Biomèdica en Red de Salud Mental (CIBERSAM), Barcelona, Spain,Department of Child and Adolescent Psychiatry and Psychology, Institute of Neurosciences, Hospital Clínic Universitari, Barcelona, Spain,Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain,Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Barcelona, Spain
| | - Yanni Liu
- Department of Psychiatry, University of Michigan, Ann Arbor, Michigan, U.S.A
| | - Christine Lochner
- SU/UCT MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa
| | - Rachel Marsh
- Columbia University Medical College, Columbia University, New York, NY, U.S.A,The Division of Child and Adolescent Psychiatry, New York State Psychiatric Institute, Columbia University, New York, NY, U.S.A
| | - Ignacio Martínez-Zalacaín
- Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain
| | - David Mataix-Cols
- Department of Clinical Neuroscience, Centre for Psychiatric Research and Education, Karolinska Institutet, Stockholm, Sweden
| | - José M. Menchón
- Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain,entro de Investigación Biomèdica en Red de Salud Mental (CIBERSAM), Barcelona, Spain,Department of Clinical Sciences, University of Barcelona, Barcelona, Spain
| | - Luciano Minuzzii
- Mood Disorders Clinic, St. Joseph’s HealthCare, Hamilton, Ontario, Canada
| | - Takashi Nakamae
- Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan,Department of Neural Computation for Decision-Making, ATR Brain Information Communiciation Research Laboratory Group, Kyoto, Japan
| | - Tomohiro Nakao
- Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
| | - Janardhanan C. Narayanaswamy
- Obsessive-Compulsive Disorder (OCD) Clinic, Department of Psychiatry National Institute of Mental Health & Neurosciences, Bangalore, India
| | - Fabrizio Piras
- Laboratory of Neuropsychiatry, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy
| | - Federica Piras
- Laboratory of Neuropsychiatry, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy
| | - Christopher Pittenger
- Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, U.S.A
| | - Y.C. Janardhan Reddy
- Obsessive-Compulsive Disorder (OCD) Clinic, Department of Psychiatry National Institute of Mental Health & Neurosciences, Bangalore, India
| | - Joao R. Sato
- Center of Mathematics, Computation and Cognition, Universidade Federal Do ABC, Santo Andre, Brazil
| | - H. Blair Simpson
- Columbia University Medical College, Columbia University, New York, NY, U.S.A,Center for OCD and Related Disorders, New York State Psychiatric Institute, New York, NY, U.S.A
| | - Noam Soreni
- Anxiety Treatment and Research Center, St. Joseph’s HealthCare, Hamilton, Ontario, Canada
| | - Carles Soriano-Mas
- Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain,entro de Investigación Biomèdica en Red de Salud Mental (CIBERSAM), Barcelona, Spain,Department of Psychobiology and Methodology of Health Sciences, Universitat Autònoma de Barcelona, Barcelona, Spain
| | - Gianfranco Spalletta
- Laboratory of Neuropsychiatry, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy,Beth K. and Stuart C. Yudofsky Division of Neuropsychiatry, Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, Texas, U.S.A
| | - Michael C. Stevens
- Yale University School of Medicine, New Haven, Connecticut, U.S.A,Clinical Neuroscience and Development Laboratory, Olin Neuropsychiatry Research Center, Hartford, Connecticut, U.S.A
| | - Philip R. Szeszko
- Icahn School of Medicine at Mount Sinai, New York, NY, U.S.A,James J. Peters VA Medical Center, Bronx, NY, U.S.A
| | - David F. Tolin
- Yale University School of Medicine, New Haven, Connecticut, U.S.A,Institute of Living/Hartford Hospital, Hartford, Connecticut, U.S.A
| | - Ganesan Venkatasubramanian
- Obsessive-Compulsive Disorder (OCD) Clinic, Department of Psychiatry National Institute of Mental Health & Neurosciences, Bangalore, India
| | - Susanne Walitza
- Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric Hospital, University of Zurich, Zurich, Switzerland
| | - Zhen Wang
- Shanghai Mental Health Center Shanghai Jiao Tong University School of Medicine, Shanghai, PR China,Shanghai Key Laboratory of Psychotic Disorders, Shanghai, PR China
| | - Guido A. van Wingen
- Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
| | - Jian Xu
- Department of Internal Medicine, First Affiliated Hospital of Kunming Medical University, Kunming, China
| | - Xiufeng Xu
- Department of Psychiatry, First Affiliated Hospital of Kunming Medical University, Kunming, China
| | - Je-Yeon Yun
- Department of Psychiatry, Seoul National University College of Medicine, Seoul, Korea
| | - Qing Zhao
- Shanghai Mental Health Center Shanghai Jiao Tong University School of Medicine, Shanghai, PR China
| | | | - Paul M. Thompson
- Imaging Genetics Center, Mark and Mary Stevens Institute for Neuroimaging & Informatics, Keck School of Medicine of the University of Southern California, Marina del Rey, California, U.S.A
| | - Dan J. Stein
- SU/UCT MRC Unit on Anxiety & Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa
| | - Odile A. van den Heuvel
- Department of Psychiatry, VU university medical center, Amsterdam, The Netherlands,Department of Anatomy & Neurosciences, VU university medical center, Amsterdam, The Netherlands,Neuroscience Campus Amsterdam, Free University/VU university medical center, Amsterdam, The Netherlands
| | - Odile A van den Heuvel
- From the Department of Psychiatry and the Department of Anatomy and Neurosciences, VU University Medical Center, Amsterdam; Neuroscience Campus Amsterdam, Free University/VU University Medical Center, Amsterdam; the Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; the Centre for Addiction and Mental Health and Hospital for Sick Children, Toronto; the Mathison Centre for Mental Health Research and Education, Cumming School of Medicine, University of Calgary, Calgary, Canada; the Department of Psychiatry, Institute of Psychiatry, University of São Paulo School of Medicine, São Paulo, Brazil; Clinical Research Group Psychiatry and Clinical Psychobiology, Division of Neuroscience, Scientific Institute Ospedale San Raffaele, Milan; the Department of Psychology, Humboldt-Universität zu Berlin, Berlin; the Obsessive-Compulsive Disorder Clinic, Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India; the Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric Hospital, University of Zurich, Zurich; Magnetic Resonance Image Core Facility, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; the Department of Psychiatry, First Affiliated Hospital of Kunming Medical University, Kunming, China; the Department of Brain and Cognitive Sciences, Seoul National University College of Natural Sciences, Seoul, Korea; the Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam; the Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences, Amsterdam; the Department of Psychiatry, University of Michigan, Ann Arbor; the Department of Psychiatry, University of Cape Town, Cape Town, South Africa; the Department of Psychiatry, University of Stellenbosch, Cape Town; the Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Centro de Investigación Biomèdica en Red de Salud Mental (CIBERSAM), Barcelona; the Department of Psychiatry, Yale University School of Medicine, New Haven, Conn.; the Imaging Genetics Center, Mark and Mary Stevens Institute for Neuroimaging and Informatics, Keck School of Medicine, University of Southern California, Marina del Rey; De Bascule, Academic Center for Child and Adolescent Psychiatry, Amsterdam; the Department of Child and Adolescent Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam; the Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; the Department of Neuroradiology, Klinikum rechts der Isar, Technische Universität München, Munich; TUM-Neuroimaging Center (TUM-NIC) of Klinikum rechts der Isar, Technische Universität München, Munich; the Department of Psychiatry, Seoul National University College of Medicine, Seoul, Korea; the Department of Child and Adolescent Psychiatry and Psychology, Institute of Neurosciences, Hospital Clínic Universitari, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona; the Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Barcelona, Spain; SU/UCT MRC Unit on Anxiety and Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa; Columbia University Medical Center, New York; the Division of Child and Adolescent Psychiatry, New York State Psychiatric Institute and Columbia University, New York; the Department of Clinical Neuroscience, Center for Psychiatric Research and Education, Karolinska Institutet, Stockholm; the Department of Clinical Sciences, University of Barcelona, Barcelona, Spain; the Mood Disorders Clinic and the Anxiety Treatment and Research Center, St. Joseph's HealthCare, Hamilton, Canada; the Department of Neural Computation for Decision Making, ATR Brain Information Communiciation Research Laboratory Group, Kyoto, Japan; the Laboratory of Neuropsychiatry, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome; the Center of Mathematics, Computation, and Cognition, Universidade Federal Do ABC, Santo Andre, Brazil; the Center for OCD and Related Disorders, New York State Psychiatric Institute, New York; the Department of Psychobiology and Methodology of Health Sciences, Universitat Autònoma de Barcelona, Barcelona, Spain; the Beth K. and Stuart C. Yudofsky Division of Neuropsychiatry, Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston; the Department of Psychiatry, Yale University School of Medicine, New Haven, Conn.; the Clinical Neuroscience and Development Laboratory, Olin Neuropsychiatry Research Center, Hartford, Conn.; the Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York; the James J. Peters VA Medical Center, Bronx, New York; the Institute of Living/Hartford Hospital, Hartford, Conn.; the Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China; the Shanghai Key Laboratory of Psychotic Disorders, Shanghai; and the Department of Internal Medicine, First Affiliated Hospital of Kunming Medical University, Kunming, China
| |
Collapse
|
13
|
Hoexter MQ, Diniz JB, Lopes AC, Batistuzzo MC, Shavitt RG, Dougherty DD, Duran FLS, Bressan RA, Busatto GF, Miguel EC, Sato JR. ORBITOFRONTAL THICKNESS AS A MEASURE FOR TREATMENT RESPONSE PREDICTION IN OBSESSIVE-COMPULSIVE DISORDER. Depress Anxiety 2015; 32:900-8. [PMID: 26032588 DOI: 10.1002/da.22380] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/09/2014] [Revised: 04/15/2015] [Accepted: 04/21/2015] [Indexed: 02/02/2023] Open
Abstract
BACKGROUND Early prediction of treatment response could reduce exposure to ineffective treatments and optimize the use of medical resources. Neuroimaging techniques have been used to identify biomarkers that are predictive of outcomes. The aims of this study were to investigate orbitofrontal cortex (OFC) thickness as a potential morphometric biomarker to discriminate outcomes in obsessive-compulsive disorder (OCD) and then to reexamine this biomarker in an independent cohort METHODS Using a logistic regression model based on the mean baseline thickness of subregions of the OFC, we estimated the probability of treatment response in 29 treatment-naïve OCD patients who participated in a clinical trial. That algorithm was then tested in an independent cohort of 12 patients with a confirmed diagnosis of refractory OCD RESULTS: Among the treatment-naïve OCD patients, measures of OFC thickness statistically significantly differentiated responders (n = 13) and nonresponders (n = 16), with an overall classification accuracy of ≈80%, a sensitivity of 77% (10/13), and a specificity of 81% (13/16). Of the refractory OCD patients in the second independent cohort, 67% were correctly classified as nonresponders. The most discriminative measures in the initial cohort of treatment-naïve patients were the thicknesses of the left and right medial OFC (P = .009 and P = .028, respectively) CONCLUSIONS We found OFC thickness to be a strong predictor of treatment response in treatment-naïve OCD patients. Although there are not yet any brain imaging biomarkers with clinical utility, our results highlight the potential of these measures as tools for predicting treatment outcomes in OCD.
Collapse
Affiliation(s)
- Marcelo Q Hoexter
- Department of Psychiatry, Institute of Psychiatry, University of São Paulo School of Medicine, São Paulo, Brazil.,Department of Psychiatry, Interdisciplinary Laboratory for Clinical Neuroscience, Federal University of São Paulo, São Paulo, Brazil.,Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Juliana B Diniz
- Department of Psychiatry, Institute of Psychiatry, University of São Paulo School of Medicine, São Paulo, Brazil
| | - Antonio C Lopes
- Department of Psychiatry, Institute of Psychiatry, University of São Paulo School of Medicine, São Paulo, Brazil
| | - Marcelo C Batistuzzo
- Department of Psychiatry, Institute of Psychiatry, University of São Paulo School of Medicine, São Paulo, Brazil
| | - Roseli G Shavitt
- Department of Psychiatry, Institute of Psychiatry, University of São Paulo School of Medicine, São Paulo, Brazil
| | - Darin D Dougherty
- Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Fabio L S Duran
- Department of Psychiatry, Institute of Psychiatry, University of São Paulo School of Medicine, São Paulo, Brazil
| | - Rodrigo A Bressan
- Department of Psychiatry, Interdisciplinary Laboratory for Clinical Neuroscience, Federal University of São Paulo, São Paulo, Brazil
| | - Geraldo F Busatto
- Department of Psychiatry, Institute of Psychiatry, University of São Paulo School of Medicine, São Paulo, Brazil
| | - Euripides C Miguel
- Department of Psychiatry, Institute of Psychiatry, University of São Paulo School of Medicine, São Paulo, Brazil
| | - Joao R Sato
- Center of Mathematics, Computation, and Cognition, Federal University of the ABC, Santo André, Brazil
| |
Collapse
|
14
|
McGuire P, Sato JR, Mechelli A, Jackowski A, Bressan RA, Zugman A. Can neuroimaging be used to predict the onset of psychosis? Lancet Psychiatry 2015; 2:1117-22. [PMID: 26521769 DOI: 10.1016/s2215-0366(15)00308-9] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/02/2015] [Revised: 06/19/2015] [Accepted: 06/29/2015] [Indexed: 12/27/2022]
Abstract
The onset of psychotic disorders is preceded by a high-risk phase characterised by attenuated or brief psychotic symptoms and a marked decline in functioning. About a third of individuals presenting with these features develop a psychotic disorder within 3 years. A fundamental challenge in the clinical management of this population is that it is not possible to predict whether an individual at high risk will go on to develop psychosis on the basis of their presenting features. Consequently, preventive interventions that might reduce the risk of progression to psychosis cannot be selectively offered to those patients for whom they would be most useful. However, neuroimaging investigation suggests that the structure, function, and chemistry of the brain in high-risk individuals who become psychotic differ from those in individuals who do not become psychotic. In this Personal View, we review these findings and discuss the main challenges for translating them into clinical practice. The development of techniques that allow clinicians to tailor interventions to the level of risk is a major translational goal for research in this field.
Collapse
Affiliation(s)
- Philip McGuire
- Department of Psychosis Studies, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK; OASIS, South London and Maudsley NHS Trust, London, UK.
| | - Joao R Sato
- Center of Mathematics, Computation and Cognition, Universidade Federal do ABC, Santo Andre, Brazil
| | - Andrea Mechelli
- Department of Psychosis Studies, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK; OASIS, South London and Maudsley NHS Trust, London, UK
| | - Andrea Jackowski
- Department of Psychiatry of the Federal University of São Paulo, São Paulo, Brazil
| | - Rodrigo A Bressan
- Department of Psychosis Studies, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK; Department of Psychiatry of the Federal University of São Paulo, São Paulo, Brazil
| | - Andre Zugman
- Department of Psychosis Studies, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK; OASIS, South London and Maudsley NHS Trust, London, UK; Department of Psychiatry of the Federal University of São Paulo, São Paulo, Brazil
| |
Collapse
|
15
|
Abstract
Accumulating evidence underscores the utility of ketamine in treating severely treatment-resistant depressed patients. We investigated the relationship between the rapid antidepressant effects of ketamine and hippocampal volume, a biomarker of antidepressant treatment outcome. We gave 16 medication-free, major depressive disorder (MDD) patients a single, sub-anesthetic dose infusion of ketamine (0.5 mg/kg, over 40 min). We assessed depression severity pre-treatment, and at 24 h post-treatment, with the Montgomery-Åsberg Depression Rating Scale (MADRS). Prior to treatment, patients underwent magnetic resonance imaging (MRI) to estimate their hippocampal volume: We obtained viable MRI data in 13 patients. Delta MADRS (post- minus pre-treatment) was significantly correlated with the pre-treatment volumes of the left hippocampus (r = 0.66; p = 0.01), but not the right hippocampus (r = 0.49; p = 0.09). The correlation between delta MADRS and the left hippocampus remained high (r > 0.6; p = 0.13), after controlling for several demographic and clinical variables, although the p value increased due to the reduced degree of freedom (df = 5). Ketamine exerts enhanced antidepressant effects in patients with a relatively smaller hippocampus, a patient population that has been repeatedly shown to be refractory to traditional antidepressants.
Collapse
Affiliation(s)
- Chadi G. Abdallah
- Clinical Neuroscience Division, National Center for PTSD, West Haven, CT, USA,Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
| | - Ramiro Salas
- Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, USA
| | - Andrea Jackowski
- LiNC, Departamento de Psiquiatria, Universidade Federal de Sao Paulo, SP, Brazil
| | - Philip Baldwin
- Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, USA
| | - Joao R. Sato
- LiNC, Departamento de Psiquiatria, Universidade Federal de Sao Paulo, SP, Brazil,Center of Mathematics, Computation and Cognition. Universidade Federal do ABC, Santo Andre, Brazil
| | - Sanjay J. Mathew
- Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, USA,Mental Health Care Line, Michael E. Debakey VA Medical Center, Houston, TX
| |
Collapse
|
16
|
Dean PJA, Sato JR, Vieira G, McNamara A, Sterr A. Multimodal imaging of mild traumatic brain injury and persistent postconcussion syndrome. Brain Behav 2015; 5:45-61. [PMID: 25722949 PMCID: PMC4321394 DOI: 10.1002/brb3.292] [Citation(s) in RCA: 40] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/15/2014] [Revised: 08/21/2014] [Accepted: 09/15/2014] [Indexed: 01/08/2023] Open
Abstract
BACKGROUND Persistent postconcussion syndrome (PCS) occurs in around 5-10% of individuals after mild traumatic brain injury (mTBI), but research into the underlying biology of these ongoing symptoms is limited and inconsistent. One reason for this could be the heterogeneity inherent to mTBI, with individualized injury mechanisms and psychological factors. A multimodal imaging study may be able to characterize the injury better. AIM To look at the relationship between functional (fMRI), structural (diffusion tensor imaging), and metabolic (magnetic resonance spectroscopy) data in the same participants in the long term (>1 year) after injury. It was hypothesized that only those mTBI participants with persistent PCS would show functional changes, and that these changes would be related to reduced structural integrity and altered metabolite concentrations. METHODS Functional changes associated with persistent PCS after mTBI (>1 year postinjury) were investigated in participants with and without PCS (both n = 8) and non-head injured participants (n = 9) during performance of working memory and attention/processing speed tasks. Correlation analyses were performed to look at the relationship between the functional data and structural and metabolic alterations in the same participants. RESULTS There were no behavioral differences between the groups, but participants with greater PCS symptoms exhibited greater activation in attention-related areas (anterior cingulate), along with reduced activation in temporal, default mode network, and working memory areas (left prefrontal) as cognitive load was increased from the easiest to the most difficult task. Functional changes in these areas correlated with reduced structural integrity in corpus callosum and anterior white matter, and reduced creatine concentration in right dorsolateral prefrontal cortex. CONCLUSION These data suggest that the top-down attentional regulation and deactivation of task-irrelevant areas may be compensating for the reduction in working memory capacity and variation in white matter transmission caused by the structural and metabolic changes after injury. This may in turn be contributing to secondary PCS symptoms such as fatigue and headache. Further research is required using multimodal data to investigate the mechanisms of injury after mTBI, but also to aid individualized diagnosis and prognosis.
Collapse
Affiliation(s)
| | - Joao R Sato
- Center of Mathematics, Computation and Cognition, Universidade Federal do ABCSão Paulo, Brazil
- NIF/LIM44, Departamento de Radiologia da Faculdade de Medicina da Universidade de São PauloSão Paulo, Brazil
| | - Gilson Vieira
- NIF/LIM44, Departamento de Radiologia da Faculdade de Medicina da Universidade de São PauloSão Paulo, Brazil
| | - Adam McNamara
- School of Psychology, University Of SurreyGuildford, UK
| | - Annette Sterr
- School of Psychology, University Of SurreyGuildford, UK
| |
Collapse
|
17
|
Miotto EC, Balardin JB, Vieira G, Sato JR, Martin MDGM, Scaff M, Teixeira MJ, Junior EA. Right inferior frontal gyrus activation is associated with memory improvement in patients with left frontal low-grade glioma resection. PLoS One 2014; 9:e105987. [PMID: 25157573 PMCID: PMC4144959 DOI: 10.1371/journal.pone.0105987] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2013] [Accepted: 07/31/2014] [Indexed: 11/30/2022] Open
Abstract
Patients with low-grade glioma (LGG) have been studied as a model of functional brain reorganization due to their slow-growing nature. However, there is no information regarding which brain areas are involved during verbal memory encoding after extensive left frontal LGG resection. In addition, it remains unknown whether these patients can improve their memory performance after instructions to apply efficient strategies. The neural correlates of verbal memory encoding were investigated in patients who had undergone extensive left frontal lobe (LFL) LGG resections and healthy controls using fMRI both before and after directed instructions were given for semantic organizational strategies. Participants were scanned during the encoding of word lists under three different conditions before and after a brief period of practice. The conditions included semantically unrelated (UR), related-non-structured (RNS), and related-structured words (RS), allowing for different levels of semantic organization. All participants improved on memory recall and semantic strategy application after the instructions for the RNS condition. Healthy subjects showed increased activation in the left inferior frontal gyrus (IFG) and middle frontal gyrus (MFG) during encoding for the RNS condition after the instructions. Patients with LFL excisions demonstrated increased activation in the right IFG for the RNS condition after instructions were given for the semantic strategies. Despite extensive damage in relevant areas that support verbal memory encoding and semantic strategy applications, patients that had undergone resections for LFL tumor could recruit the right-sided contralateral homologous areas after instructions were given and semantic strategies were practiced. These results provide insights into changes in brain activation areas typically implicated in verbal memory encoding and semantic processing.
Collapse
Affiliation(s)
- Eliane C. Miotto
- Department of Neurology, University of São Paulo, São Paulo, Brazil
- * E-mail:
| | | | - Gilson Vieira
- Department of Radiology, University of São Paulo, São Paulo, Brazil
| | - Joao R. Sato
- Centre of Mathematics, Computation and Cognition, Universidade Federal ABC, Santo Andre, Brazil
| | | | - Milberto Scaff
- Department of Neurology, University of São Paulo, São Paulo, Brazil
| | | | | |
Collapse
|
18
|
Cerqueira CT, Sato JR, de Almeida JRC, Amaro E, Leite CC, Gorenstein C, Gentil V, Busatto GF. Healthy individuals treated with clomipramine: an fMRI study of brain activity during autobiographical recall of emotions. Transl Psychiatry 2014; 4:e405. [PMID: 24984192 PMCID: PMC4080327 DOI: 10.1038/tp.2014.47] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/02/2014] [Accepted: 04/22/2014] [Indexed: 12/14/2022] Open
Abstract
Various functional magnetic resonance imaging studies addressed the effects of antidepressant drugs on brain functioning in healthy subjects; however, none specifically investigated positive mood changes to antidepressant drug. Sixteen subjects with no personal or family history of psychiatric disorders were selected from an ongoing 4-week open trial of small doses of clomipramine. Follow-up interviews documented clear positive treatment effects in six subjects, with reduced irritability and tension in social interactions, improved decision making, higher self-confidence and brighter mood. These subjects were then included in a placebo-controlled confirmatory trial and were scanned immediately after 4 weeks of clomipramine use and again 4 weeks after the last dose of clomipramine. The functional magnetic resonance imaging (fMRI) scans were run during emotion-eliciting stimuli. Repeated-measures analysis of variance of brain activity patterns showed significant interactions between group and treatment status during induced irritability (P<0.005 cluster-based) but not during happiness. Individuals displaying a positive subjective response do clomipramine had higher frontoparietal cortex activity during irritability than during happiness and neutral emotion, and higher temporo-parieto-occipital cortex activity during irritability than during happiness. We conclude that antidepressants not only induce positive mood responses but also act upon autobiographical recall of negative emotions.
Collapse
Affiliation(s)
- C T Cerqueira
- Department and Institute of Psychiatry, School of Medicine and Hospital das Clínicas, University of São Paulo, São Paulo, Brazil,Department and Institute of Psychiatry, School of Medicine and Hospital das Clínicas, University of São Paulo, Rua Dr Ovídio Pires de Campos 785, São Paulo, SP 05430-010, Brazil. E-mail:
| | - J R Sato
- Department of Cognitive Neuroscience, Federal University of the ABC, Santo André, Brazil,Department and Institute of Radiology, School of Medicine, University of São Paulo, São Paulo, Brazil
| | - J R C de Almeida
- Department of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
| | - E Amaro
- Department and Institute of Radiology, School of Medicine, University of São Paulo, São Paulo, Brazil
| | - C C Leite
- Department and Institute of Radiology, School of Medicine, University of São Paulo, São Paulo, Brazil
| | - C Gorenstein
- Department and Institute of Psychiatry, School of Medicine and Hospital das Clínicas, University of São Paulo, São Paulo, Brazil,Laboratory of Psychopharmacology (LIM 23), School of Medicine, USP, São Paulo, Brazil,Department of Pharmacology, Institute of Biomedical Sciences, USP, São Paulo, Brazil
| | - V Gentil
- Department and Institute of Psychiatry, School of Medicine and Hospital das Clínicas, University of São Paulo, São Paulo, Brazil
| | - G F Busatto
- Department and Institute of Psychiatry, School of Medicine and Hospital das Clínicas, University of São Paulo, São Paulo, Brazil
| |
Collapse
|
19
|
Linares IMP, Jackowski AP, Trzesniak CMF, Arrais KC, Chagas MHN, Sato JR, Santos AC, Hallak JEC, Zuardi AW, Nardi AE, Coimbra NC, Crippa JAS. Cortical thinning of the right anterior cingulate cortex in spider phobia: a magnetic resonance imaging and spectroscopy study. Brain Res 2014; 1576:35-42. [PMID: 24892191 DOI: 10.1016/j.brainres.2014.05.040] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2014] [Revised: 05/21/2014] [Accepted: 05/26/2014] [Indexed: 10/25/2022]
Abstract
There a lack of consistent neuroimaging data on specific phobia (SP) and a need to assess volumetric and metabolic differences in structures implicated in this condition. The aim of this study is investigate possible metabolic (via (1)H MRS) and cortical thickness abnormalities in spider-phobic patients compared to healthy volunteers. Participants were recruited via public advertisement and underwent clinical evaluations and MRI scans. The study started in 2010 and the investigators involved were not blind in respect to patient groupings. The study was conducted at the Ribeirão Preto Medical School University Hospital of the University of São Paulo, Brazil. Patients with spider phobia (n=19) were matched to 17 healthy volunteers with respect to age, education and socio-economic status. The spider SP group fulfilled the diagnostic criteria for spider phobia according to the Structured Clinical Interview for DSM-IV. None of the participants had a history of neurological, psychiatric or other relevant organic diseases, use of prescribed psychotropic medication or substance abuse. All imaging and spectroscopy data were collected with a 3 T MRI scanner equipped with 25 mT gradient coils in 30-minute scans. The Freesurfer image analysis package and LC Model software were used to analyze data. The hypothesis being tested was formulated before the data collection (neural correlates of SP would include the amygdala, insula, anterior cingulate gyrus and others). The results indicated the absence of metabolic alterations, but thinning of the right anterior cingulate cortex (ACC) in the SP group when compared to the healthy control group (mean cortical thickness±SD: SP=2.11±0.45 mm; HC=2.16±0.42 mm; t (34)=3.19, p=0.001 [-35.45, 71.00, -23.82]). In spectroscopy, the ratios between N-acetylaspartate and creatine and choline levels were measured. No significant effect or correlation was found between MRS metabolites and scores in the Spider Phobia Questionnaire and Beck Anxiety Inventory (p>0.05). The ACC is known to be related to the cognitive processing of fear and anxiety and to be linked with the conditioning circuit. The MRS findings are preliminary and need more studies. The finding of reduced ACC thickness in SP is in agreement with evidence from previous functional neuroimaging studies and highlights the importance of this brain area in the pathophysiology of SP.
Collapse
Affiliation(s)
- I M P Linares
- Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, National Institute for Translational Medicine (INCT, CNPq), Ribeirão Preto, São Paulo, Brazil.
| | - A P Jackowski
- Laboratory of Interdisciplinary Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil
| | - C M F Trzesniak
- Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, National Institute for Translational Medicine (INCT, CNPq), Ribeirão Preto, São Paulo, Brazil
| | - K C Arrais
- Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, National Institute for Translational Medicine (INCT, CNPq), Ribeirão Preto, São Paulo, Brazil
| | - M H N Chagas
- Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, National Institute for Translational Medicine (INCT, CNPq), Ribeirão Preto, São Paulo, Brazil
| | - J R Sato
- Center of Mathematics, Computation and Cognition, Universidade Federal do ABC, Santo André, Brazil
| | - A C Santos
- Department of Medical Clinic Department, Division of Radiology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil
| | - J E C Hallak
- Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, National Institute for Translational Medicine (INCT, CNPq), Ribeirão Preto, São Paulo, Brazil
| | - A W Zuardi
- Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, National Institute for Translational Medicine (INCT, CNPq), Ribeirão Preto, São Paulo, Brazil
| | - A E Nardi
- Laboratory of Panic and Respiration, Institute of Psychiatry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
| | - N C Coimbra
- Laboratory of Neuroanatomy & Neuropsychobiology, Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil
| | - J A S Crippa
- Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, National Institute for Translational Medicine (INCT, CNPq), Ribeirão Preto, São Paulo, Brazil
| |
Collapse
|
20
|
de Wit SJ, Alonso P, Schweren L, Mataix-Cols D, Lochner C, Menchón JM, Stein DJ, Fouche JP, Soriano-Mas C, Sato JR, Hoexter MQ, Denys D, Nakamae T, Nishida S, Kwon JS, Jang JH, Busatto GF, Cardoner N, Cath DC, Fukui K, Jung WH, Kim SN, Miguel EC, Narumoto J, Phillips ML, Pujol J, Remijnse PL, Sakai Y, Shin NY, Yamada K, Veltman DJ, van den Heuvel OA. Multicenter voxel-based morphometry mega-analysis of structural brain scans in obsessive-compulsive disorder. Am J Psychiatry 2014; 171:340-9. [PMID: 24220667 DOI: 10.1176/appi.ajp.2013.13040574] [Citation(s) in RCA: 194] [Impact Index Per Article: 19.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
OBJECTIVE Results from structural neuroimaging studies of obsessive-compulsive disorder (OCD) have been only partially consistent. The authors sought to assess regional gray and white matter volume differences between large samples of OCD patients and healthy comparison subjects and their relation with demographic and clinical variables. METHOD A multicenter voxel-based morphometry mega-analysis was performed on 1.5-T structural T1-weighted MRI scans derived from the International OCD Brain Imaging Consortium. Regional gray and white matter brain volumes were compared between 412 adult OCD patients and 368 healthy subjects. RESULTS Relative to healthy comparison subjects, OCD patients had significantly smaller volumes of frontal gray and white matter bilaterally, including the dorsomedial prefrontal cortex, the anterior cingulate cortex, and the inferior frontal gyrus extending to the anterior insula. Patients also showed greater cerebellar gray matter volume bilaterally compared with healthy subjects. Group differences in frontal gray and white matter volume were significant after correction for multiple comparisons. Additionally, group-by-age interactions were observed in the putamen, insula, and orbitofrontal cortex (indicating relative preservation of volume in patients compared with healthy subjects with increasing age) and in the temporal cortex bilaterally (indicating a relative loss of volume in patients compared with healthy subjects with increasing age). CONCLUSIONS These findings partially support the prevailing fronto-striatal models of OCD and offer additional insights into the neuroanatomy of the disorder that were not apparent from previous smaller studies. The group-by-age interaction effects in orbitofrontal-striatal and (para)limbic brain regions may be the result of altered neuroplasticity associated with chronic compulsive behaviors, anxiety, or compensatory processes related to cognitive dysfunction.
Collapse
|
21
|
Mourão-Miranda J, Almeida JRC, Hassel S, de Oliveira L, Versace A, Marquand AF, Sato JR, Brammer M, Phillips ML. Pattern recognition analyses of brain activation elicited by happy and neutral faces in unipolar and bipolar depression. Bipolar Disord 2012; 14:451-60. [PMID: 22631624 PMCID: PMC3510302 DOI: 10.1111/j.1399-5618.2012.01019.x] [Citation(s) in RCA: 63] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
Abstract
OBJECTIVES Recently, pattern recognition approaches have been used to classify patterns of brain activity elicited by sensory or cognitive processes. In the clinical context, these approaches have been mainly applied to classify groups of individuals based on structural magnetic resonance imaging (MRI) data. Only a few studies have applied similar methods to functional MRI (fMRI) data. METHODS We used a novel analytic framework to examine the extent to which unipolar and bipolar depressed individuals differed on discrimination between patterns of neural activity for happy and neutral faces. We used data from 18 currently depressed individuals with bipolar I disorder (BD) and 18 currently depressed individuals with recurrent unipolar depression (UD), matched on depression severity, age, and illness duration, and 18 age- and gender ratio-matched healthy comparison subjects (HC). fMRI data were analyzed using a general linear model and Gaussian process classifiers. RESULTS The accuracy for discriminating between patterns of neural activity for happy versus neutral faces overall was lower in both patient groups relative to HC. The predictive probabilities for intense and mild happy faces were higher in HC than in BD, and for mild happy faces were higher in HC than UD (all p < 0.001). Interestingly, the predictive probability for intense happy faces was significantly higher in UD than BD (p = 0.03). CONCLUSIONS These results indicate that patterns of whole-brain neural activity to intense happy faces were significantly less distinct from those for neutral faces in BD than in either HC or UD. These findings indicate that pattern recognition approaches can be used to identify abnormal brain activity patterns in patient populations and have promising clinical utility as techniques that can help to discriminate between patients with different psychiatric illnesses.
Collapse
Affiliation(s)
- Janaina Mourão-Miranda
- Department of Computer Science, Centre for Computational Statistics and Machine Learning, University College London, London, UK.
| | - Jorge RC Almeida
- Department of Psychiatry, University of Pittsburgh School of MedicinePittsburgh, PA, USA
| | - Stefanie Hassel
- Department of Psychiatry, University of Pittsburgh School of MedicinePittsburgh, PA, USA
| | - Leticia de Oliveira
- Department of Neuroimaging, King's College LondonLondon, UK,Instituto Biomédico, Universidade Federal FluminenseRio de Janeiro
| | - Amelia Versace
- Department of Psychiatry, University of Pittsburgh School of MedicinePittsburgh, PA, USA
| | | | - Joao R Sato
- Center of Mathematics, Computation and Cognition, Universidade Federal do ABCSanto André, Brazil
| | - Michael Brammer
- Department of Clinical Neuroscience, Institute of Psychiatry, King’s College LondonLondon
| | - Mary L Phillips
- Department of Psychiatry, University of Pittsburgh School of MedicinePittsburgh, PA, USA,Department of Psychological Medicine, Cardiff UniversityCardiff, UK
| |
Collapse
|
22
|
Cerqueira CT, Almeida JRC, Gorenstein C, Gentil V, Leite CC, Sato JR, Amaro E, Busatto GF. Engagement of multifocal neural circuits during recall of autobiographical happy events. Braz J Med Biol Res 2009; 41:1076-85. [PMID: 19148369 DOI: 10.1590/s0100-879x2008001200006] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2008] [Accepted: 12/08/2008] [Indexed: 11/21/2022] Open
Abstract
Happy emotional states have not been extensively explored in functional magnetic resonance imaging studies using autobiographic recall paradigms. We investigated the brain circuitry engaged during induction of happiness by standardized script-driven autobiographical recall in 11 healthy subjects (6 males), aged 32.4 +/- 7.2 years, without physical or psychiatric disorders, selected according to their ability to vividly recall personal experiences. Blood oxygen level-dependent (BOLD) changes were recorded during auditory presentation of personal scripts of happiness, neutral content and negative emotional content (irritability). The same uniform structure was used for the cueing narratives of both emotionally salient and neutral conditions, in order to decrease the variability of findings. In the happiness relative to the neutral condition, there was an increased BOLD signal in the left dorsal prefrontal cortex and anterior insula, thalamus bilaterally, left hypothalamus, left anterior cingulate gyrus, and midportions of the left middle temporal gyrus (P < 0.05, corrected for multiple comparisons). Relative to the irritability condition, the happiness condition showed increased activity in the left insula, thalamus and hypothalamus, and in anterior and midportions of the inferior and middle temporal gyri bilaterally (P < 0.05, corrected), varying in size between 13 and 64 voxels. Findings of happiness-related increased activity in prefrontal and subcortical regions extend the results of previous functional imaging studies of autobiographical recall. The BOLD signal changes identified reflect general aspects of emotional processing, emotional control, and the processing of sensory and bodily signals associated with internally generated feelings of happiness. These results reinforce the notion that happiness induction engages a wide network of brain regions.
Collapse
Affiliation(s)
- C T Cerqueira
- Departamento de Psiquiatria, Universidade de São Paulo, São Paulo, SP, Brasil
| | | | | | | | | | | | | | | |
Collapse
|
23
|
Lessa PS, Sato JR, Neto CG, Valadares AP, Cardoso EF, Amaro E. Wavelet Partial Correlation: identifying functional connectivity at time resolution of neurophysiologic processes. Neuroimage 2009. [DOI: 10.1016/s1053-8119(09)70247-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
24
|
Brito CSN, Sato JR, Baccalá LA, Amaro E, Brammer M, Sameshima K. Directed functional connectivity analysis on resting-state networks. Neuroimage 2009. [DOI: 10.1016/s1053-8119(09)71512-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
25
|
Sato JR, Thomaz CE, Cardoso EF, Fujita A, Morais-Martin MG, Amaro E. Individual latent state scoring based on Hyperplane Navigation. Neuroimage 2009. [DOI: 10.1016/s1053-8119(09)70544-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
26
|
Cardoso EF, Fregni F, Maia FM, Melo LM, Sato JR, Cruz ACM, Bianchi ET, Barbosa ER, Amaro E. fMRI changes in the visual cortex of patients with Parkinson's Disease. Neuroimage 2009. [DOI: 10.1016/s1053-8119(09)71065-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
27
|
Biazoli CE, Sato JR, Cardoso EF, Amaro E. Non-linear Estimation of Regional Processing Time from BOLD Effect Shows Modulation of the Anterior Cingulate Gyrus and Right Dorsal-lateral Prefrontal Cortex by Emotional Distracters. Neuroimage 2009. [DOI: 10.1016/s1053-8119(09)70880-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
28
|
Mourao-Miranda J, Ecker C, Sato JR, Brammer M. Dynamic changes in the mental rotation network revealed by pattern recognition analysis of fMRI data. J Cogn Neurosci 2009; 21:890-904. [PMID: 18702583 DOI: 10.1162/jocn.2009.21078] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
We investigated the temporal dynamics and changes in connectivity in the mental rotation network through the application of spatio-temporal support vector machines (SVMs). The spatio-temporal SVM [Mourao-Miranda, J., Friston, K. J., et al. (2007). Dynamic discrimination analysis: A spatial-temporal SVM. Neuroimage, 36, 88-99] is a pattern recognition approach that is suitable for investigating dynamic changes in the brain network during a complex mental task. It does not require a model describing each component of the task and the precise shape of the BOLD impulse response. By defining a time window including a cognitive event, one can use spatio-temporal fMRI observations from two cognitive states to train the SVM. During the training, the SVM finds the discriminating pattern between the two states and produces a discriminating weight vector encompassing both voxels and time (i.e., spatio-temporal maps). We showed that by applying spatio-temporal SVM to an event-related mental rotation experiment, it is possible to discriminate between different degrees of angular disparity (0 degrees vs. 20 degrees , 0 degrees vs. 60 degrees , and 0 degrees vs. 100 degrees ), and the discrimination accuracy is correlated with the difference in angular disparity between the conditions. For the comparison with highest accuracy (0 degrees vs. 100 degrees ), we evaluated how the most discriminating areas (visual regions, parietal regions, supplementary, and premotor areas) change their behavior over time. The frontal premotor regions became highly discriminating earlier than the superior parietal cortex. There seems to be a parcellation of the parietal regions with an earlier discrimination of the inferior parietal lobe in the mental rotation in relation to the superior parietal. The SVM also identified a network of regions that had a decrease in BOLD responses during the 100 degrees condition in relation to the 0 degrees condition (posterior cingulate, frontal, and superior temporal gyrus). This network was also highly discriminating between the two conditions. In addition, we investigated changes in functional connectivity between the most discriminating areas identified by the spatio-temporal SVM. We observed an increase in functional connectivity between almost all areas activated during the 100 degrees condition (bilateral inferior and superior parietal lobe, bilateral premotor area, and SMA) but not between the areas that showed a decrease in BOLD response during the 100 degrees condition.
Collapse
|
29
|
Fujita A, Sato JR, Festa F, Gomes LR, Oba-Shinjo SM, Marie SKN, Ferreira CE, Sogayar MC. Identification of COL6A1 as a differentially expressed gene in human astrocytomas. Genet Mol Res 2008; 7:371-8. [PMID: 18551403 DOI: 10.4238/vol7-2gmr432] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Diffuse infiltrating gliomas are the most common tumors of the central nervous system. Gliomas are classified by the WHO according to their histopathological and clinical characteristics into four classes: grade I (pilocytic astrocytoma), grade II (diffuse astrocytoma), grade III (anaplastic astrocytoma), and grade IV (glioblastoma multiforme). Several genes have already been correlated with astrocytomas, but many others are yet to be uncovered. By analyzing the public SAGE data from 21 patients, comprising low malignant grade astrocytomas and glioblastomas, we found COL6A1 to be differentially expressed, confirming this finding by real time RT-PCR in 66 surgical samples. To the best of our knowledge, COL6A1 has never been described in gliomas. The expression of this gene has significantly different means when normal glia is compared with low-grade astrocytomas (grades I and II) and high-grade astrocytomas (grades III and IV), with a tendency to be greater in higher grade samples, thus rendering it a powerful tumor marker.
Collapse
Affiliation(s)
- A Fujita
- Instituto de Química, Universidade de São Paulo, São Paulo, SP, Brasil
| | | | | | | | | | | | | | | |
Collapse
|
30
|
Lucato LT, Guedes MS, Sato JR, Bacheschi LA, Machado LR, Leite CC. The role of conventional MR imaging sequences in the evaluation of neurocysticercosis: impact on characterization of the scolex and lesion burden. AJNR Am J Neuroradiol 2007; 28:1501-4. [PMID: 17846200 PMCID: PMC8134382 DOI: 10.3174/ajnr.a0623] [Citation(s) in RCA: 59] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
BACKGROUND AND PURPOSE There are few studies comparing the capacity of lesion detection of conventional MR imaging in neurocysticercosis (NCC). This study was designed to clarify its role in the evaluation of this disease, focusing on the total number of lesions identified and the characterization of the scolex. MATERIALS AND METHODS MR images from 115 patients were prospectively collected during a 3-year interval, including axial spin-echo (SE) T1-weighted; axial fast SE T2-weighted; axial fluid-attenuated inversion recovery (FLAIR); and gadolinium-enhanced axial, coronal, and sagittal SE T1-weighted sequences. They were compared regarding the potential for detection of NCC lesions and specifically of the scolex. RESULTS Comparing all sequences, we found that FLAIR images were more sensitive to the detection of the scolex (P < .003), whereas the last gadolinium-enhanced T1-weighted series (coronal or sagittal) identified the highest number of lesions (P < .001). CONCLUSION When dealing with NCC, optimal MR imaging protocols should include FLAIR images to obtain maximal rates of scolex detection. Special attention should be paid to the last gadolinium-enhanced sequence, which maximizes the quantification of lesion load.
Collapse
Affiliation(s)
- L T Lucato
- Department of Radiology, Clinics Hospital of the University of São Paulo, School of Medicine, São Paulo, Brazil.
| | | | | | | | | | | |
Collapse
|
31
|
Leite CC, Lucato LT, Sato JR, Valente KD, Otaduy MCG. Multivoxel proton MR spectroscopy in malformations of cortical development. AJNR Am J Neuroradiol 2007; 28:1071-5; discussion 1076-7. [PMID: 17569960 PMCID: PMC8134160 DOI: 10.3174/ajnr.a0511] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2006] [Accepted: 11/02/2006] [Indexed: 11/07/2022]
Abstract
BACKGROUND AND PURPOSE Malformations of cortical development (MCD) are traditionally considered as a cause of epilepsy. Our aim was to study patients with focal MCD, by using multivoxel proton MR spectroscopy; we focused not only on the lesion but also on the normal-appearing contralateral side (NACS). Our hypothesis was that the metabolic abnormality extends to the NACS; therefore, it would be inadequate to consider NACS as an internal control. MATERIALS AND METHODS We studied 16 patients with focal MCD. MR spectroscopy was performed by using a point-resolved spectroscopy sequence technique, including the MCD area and the NACS. In each volume of interest, a smaller volume of interest of 2.25 cm(3) centered on the MCD was selected to study the N-acetylaspartate/creatine (NAA/Cr) ratio. In NACS, this ratio was studied by placing a symmetric voxel in comparison with the smaller MCD volume of interest. A control group (n=30) was also studied to evaluate both white and gray matter by using the same MR spectroscopy protocol. RESULTS From 16 analyzed volumes of interest with MCD, 9 were composed of gray matter heterotopia and 7 of cortical dysplasia. MR spectroscopy of both MCD lesions and NACS (n=10) showed decreased NAA/Cr compared with that of the control group. NACS in these patients did not present significant differences regarding NAA/Cr in comparison with the affected side. CONCLUSIONS MR spectroscopy demonstrated abnormal NAA/Cr in both MCD lesions and NACS in patients harboring focal MCD, giving support to the hypothesis that in MCD metabolic abnormalities extend far away from the limits of the lesion, reaching the contralateral side.
Collapse
Affiliation(s)
- C C Leite
- Department of Radiology, University of São Paulo School of Medicine, São Paulo, Brazil.
| | | | | | | | | |
Collapse
|
32
|
Fujita A, Sato JR, Garay-Malpartida HM, Morettin PA, Sogayar MC, Ferreira CE. Time-varying modeling of gene expression regulatory networks using the wavelet dynamic vector autoregressive method. ACTA ACUST UNITED AC 2007; 23:1623-30. [PMID: 17463021 DOI: 10.1093/bioinformatics/btm151] [Citation(s) in RCA: 49] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
MOTIVATION A variety of biological cellular processes are achieved through a variety of extracellular regulators, signal transduction, protein-protein interactions and differential gene expression. Understanding of the mechanisms underlying these processes requires detailed molecular description of the protein and gene networks involved. To better understand these molecular networks, we propose a statistical method to estimate time-varying gene regulatory networks from time series microarray data. One well known problem when inferring connectivity in gene regulatory networks is the fact that the relationships found constitute correlations that do not allow inferring causation, for which, a priori biological knowledge is required. Moreover, it is also necessary to know the time period at which this causation occurs. Here, we present the Dynamic Vector Autoregressive model as a solution to these problems. RESULTS We have applied the Dynamic Vector Autoregressive model to estimate time-varying gene regulatory networks based on gene expression profiles obtained from microarray experiments. The network is determined entirely based on gene expression profiles data, without any prior biological knowledge. Through construction of three gene regulatory networks (of p53, NF-kappaB and c-myc) for HeLa cells, we were able to predict the connectivity, Granger-causality and dynamics of the information flow in these networks. SUPPLEMENTARY INFORMATION Additional figures may be found at http://mariwork.iq.usp.br/dvar/.
Collapse
Affiliation(s)
- A Fujita
- Institute of Mathematics and Statistics, University of São Paulo, Rua do Matão, 1010-São Paulo, 05508-090, SP, Brazil
| | | | | | | | | | | |
Collapse
|